Functional Analysis of CCR4-NOT Complex in Pancreatic β Cell by Dina Mostafa
Functional Analysis of CCR4-NOT Complex in
Pancreatic β Cell
Author Dina Mostafa
Degree Conferral
Date
2020-02-29
Degree Doctor of Philosophy
Degree Referral
Number
38005甲第43号
Copyright
Information
(C) 2020 The Author. 
URL http://doi.org/10.15102/1394.00001210
i 
 
Okinawa Institute of Science and Technology  
Graduate University  
 
Thesis submitted for the degree  
Doctor of Philosophy  
 
 
Functional Analysis of CCR4-NOT 
Complex in Pancreatic β Cell 
 
 
 
 by 
Dina Mostafa 
 
 
 
Under the Supervision of: 
Prof. Dr. Tadashi Yamamoto 
 
February 2020 
ii 
 
Declaration of Original and Sole Authorship 
 
I, Dina Mostafa Abdel Azim Mostafa, declare that this thesis entitled “Functional analysis 
of CCR4-NOT complex in pancreatic β cell” and the data presented in it are original and 
my own work. 
I confirm that: 
• This work was done solely while a candidate for the research degree at the Okinawa 
Institute of Science and Technology Graduate University, Japan. 
• No part of this work has previously been submitted for a degree at this or any other 
university. 
• References to the work of others have been clearly attributed. Quotations from the work 
of others have been clearly indicated and attributed to them. 
• In cases where others have contributed to part of this work, such contribution has been 
clearly acknowledged and distinguished from my own work. 
• None of this work has been previously published elsewhere with the exception of the 
following: 
Dina Mostafa, Akinori Takahashi, Akiko Yanagiya, Tomokazu Yamaguchi, Takaya Abe, 
Taku Kureha, Keiji Kuba, Yumi Kanegae, Yasuhide Furuta, Tadashi Yamamoto and Toru 
Suzuki. Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex 
in mRNA regulation and cell viability. RNA Biology. 2020;17(3):403-16. 
 
Signature:  
 
Date: 6th February, 2020  
iii 
 
Abstract 
Functional analysis of CCR4-NOT complex in pancreatic β cell 
Pancreatic β cells are responsible for production and secretion of insulin in response to 
increasing blood glucose levels. Therefore, defects in pancreatic β cell function lead to 
hyperglycemia and diabetes mellitus. While extensive research has focused on signaling, 
transcriptional, and epigenetic regulation in β cells, how post-transcriptional mechanisms 
influence the β cell gene expression program is largely unknown. The carbon catabolite 
repression 4 (CCR4)–negative on TATA-less (NOT) complex (CCR4-NOT complex), a major 
deadenylase conserved in eukaryotes, catalyzes mRNA deadenylation which is the rate limiting 
step in mRNA decay pathway. The CCR4-NOT complex has been implicated in the 
development of metabolic diseases. However, whether the CCR4-NOT complex affects β cell 
function is not addressed. In this thesis, I aim to understand the importance of post-
transcriptional regulation in β cells by generating mice lacking the Cnot3 gene, which encodes 
an essential CCR4-NOT complex subunit, in β cells. Suppression of CNOT3 in β cells caused 
β cell dysfunction and diabetes. This was associated with the decreased expression of β cell-
specific genes and increased expression of genes specifically repressed in β cells, called “β cell 
disallowed genes”. By combining whole transcriptome and proteome analyses and subsequent 
validations using quantitative PCR (qPCR) and immunoblot analyses, I found that mRNA and 
protein expression patterns were largely different from normal β cells upon CNOT3 
suppression, which was clearly relevant to the observed phenotypes. I also found that some β 
cell disallowed genes were stabilized in the absence of CNOT3, suggesting that their 
expression was maintained at low levels under the control of the CCR4-NOT complex. 
Together, this study uncovered mRNA deadenylation by CCR4-NOT complex as a novel 
molecular mechanism by which β cell identity and function are regulated.  
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 Chapter 1: General Introduction 
1.1 Introduction to Diabetes 
Diabetes is one of the largest global health emergencies in the 21st Century. The latest global 
trends show 463 million people have diabetes and this is predicted to rise by 51% by the year 
2045 (IDF Diabetes Atlas ninth edition, 2019). Diabetes is characterized by hyperglycemia due 
to defective insulin secretion by pancreatic β cells, defective insulin action (termed insulin 
resistance) or both. Thus, diabetes is widely defined by two forms: type 1 diabetes (T1D) that 
develops due to an autoimmune response against pancreatic β cells; and type 2 diabetes (T2D) 
which is more common in adults and is associated initially with insulin resistance that 
progresses to loss of β cell mass and function (Butler et al., 2003; Rosengren et al., 2012).   
Type 2 diabetes is a complex metabolic disorder caused by a combination of genetic 
and environmental factors. Obesity is one of the main risk factors for the development of T2D. 
Obesity contributes to insulin resistance early before the onset of T2D. At this stage, β cell 
undergoes compensatory changes releasing more insulin to compensate for the increased 
metabolic demand due to insulin resistance. Notably, glucose and free fatty acids are important 
nutrients for the β cell that essentially regulate its function and proliferation. They regulate the 
expression of multiple genes involved in energy metabolism, insulin biosynthesis/ secretion, 
intracellular signaling and gene transcription (Schuit et al., 2002). However, chronic exposure 
to high blood glucose and these lipids causes β cell dysfunction associated with β cell apoptosis. 
How the nutrient environment modulates the β cell response during adaptation to such 
diabetogenic conditions is not completely understood (Blandino-Rosano et al., 2016). Possibly, 
this adaptation involves alterations in the expression of genes essential for β cell function. Not 
only the metabolic factors contribute to β cell dysfunction but also insulin resistance is 
accompanied by a state of chronic low-grade inflammation which adversely affects β cell 
function (Shoelson et al., 2006). 
1.2 The islets of Langerhans and β cell origin 
The pancreas is an important metabolic glandular organ that has both exocrine and endocrine 
functions (Edlund, 2002). The exocrine pancreas consists of acinar and ductal cells and is 
responsible for the production and release of digestive enzymes into the duodenum.  The islets 
of Langerhans constitute its endocrine part. The islets consist of groups of specialized cells that 
produce and secrete hormones essential for maintaining glucose homeostasis. These cells 
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include β, α, , PP and  cells that secrete the islet hormones insulin, glucagon (GLUC), 
somatostatin (SST), pancreatic polypeptide (PPT) and ghrelin respectively (Shih et al., 2013). 
The islets represent only ~1-2% of the total pancreas, the insulin-secreting β cells represent at 
least ~65-80% of the islet mass, which means β cells are the most abundant of the cell types 
within the islets (an illustration of the islet structure is shown in Figure 1.1) (MacDonald and 
Rorsman, 2006).  
 
Figure 1.1 An overview of the pancreas anatomy and the islet architecture 
The figure shows the architecture of the mouse islet with centrally located β cells and other 
islet cells located on the periphery (MacDonald and Rorsman, 2006).  
Paracrine signaling between these different cell types is essential to regulate β cell 
function (Halban et al., 1982). During development, these different cell types originate from a 
progenitor cell that expresses Neurogenin3 (Ngn3), a transcription factor required for endocrine 
cell differentiation in the pancreas (Edlund, 2002). Eventually, transcription factors such as 
Pdx1, Pax4, Nkx2.2, Nkx6.1, MafA, and Foxo1 maintain the β cell identity (Ziv et al., 2013). 
However, the existence of β cell progenitors in the adult pancreas remains controversial and 
unclear. Current evidence suggests that the primary mechanism of adult β cells 
proliferation/expansion is self-replication of pre-existing cells rather than differentiation from 
stem cells (Georgia and Bhushan, 2004; Meier et al., 2008). Yet there are reports that 
multipotent cells exist within the adult pancreas and could differentiate into β cells (Xu et al., 
2008). Interestingly, some studies also demonstrated that α and  cells could transdifferentiate 
into β-like cells during conditions of extreme β cell loss in mice (Chera et al., 2014; Thorel et 
al., 2010). On the other hand, primary human β cells are capable of converting into α cells 
(Spijker et al., 2013). In addition, other studies demonstrated that the β cells can dedifferentiate 
into progenitor cells upon loss of any of the aforementioned β cell-specific transcription factors 
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during the development of diabetes (Nishimura et al., 2015; Wang et al., 2014). β cell 
dedifferentiation is now recognized as a mechanism of β cell loss in T2D (Talchai et al., 2012). 
1.3 Insulin biosynthesis 
Pancreatic β cells are essential for maintaining blood glucose homeostasis by producing and 
secreting insulin into circulation where insulin acts on insulin-sensitive tissues, including 
muscle, liver and adipocytes. The amount of insulin released is proportional to blood glucose 
levels. In addition to its stimulation of insulin release, glucose activates the transcription of the 
gene encoding preproinsulin (simply “the insulin gene”). Insulin gene expression is a highly 
regulated process that is dependent on the intricate balance between transcriptional activators 
and repressors acting upon the insulin promotor (Andrali et al., 2008). Transcriptional 
activators include Pdx1, MafA, NeuroD, Pax6, Nkx2.2 and Nkx6.1 (reviewed in (Cerf, 2006), 
while transcriptional repressors include Hes1, Insm1/A1, Sox6, Bhlhe22 and Crem (Melkman-
Zehavi et al., 2011). Glucose is known to exert a pleiotropic role in insulin gene expression 
both transcriptionally and post-transcriptionally. During insulin transcription, glucose recruits 
transcriptional activators to the insulin promotor. Additionally, glucose stabilizes preproinsulin 
mRNA through binding of polypyrimidine tract-binding protein to pyrimidine-rich sequences 
in the 3’untranslated region (3’UTR) (Poitout et al., 2006).   
Preproinsulin contains a signal peptide that is cleaved in the endoplasmic reticulum, 
yielding proinsulin. Proinsulin is then further processed by prohormone convertases (PC1/3 
and PC2) and carboxypeptidase E (CPE) to active insulin as it is packaged in insulin secretory 
granules in the Golgi apparatus (Goodge and Hutton, 2000). Eventually, mature insulin resides 
in insulin granules as a reserve pool within the β cell, in which <1% of the granules are docked 
and primed at the plasma membrane (Olofsson et al., 2002). The release of insulin from primed 
granules corresponds to 1st phase insulin secretion while its release from granules within the 
larger reserve pool represents the 2nd phase insulin secretion (Eliasson et al., 2008).  
1.4 Glucose-stimulated insulin secretion 
Glucose-stimulated insulin secretion (GSIS) is a pivotal process in the β cell that controls 
glucose homeostasis (Ashcroft and Rorsman, 2004).  This process is highly dynamic and is 
primarily regulated by the levels of extracellular glucose. Other regulators involve hormonal 
factors such as gastrointestinal hormones incretins i.e., glucagon-like peptide 1 (GLP-1) and 
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glucose-dependent insulinotropic polypeptide (GIP) and neural factors. Any dysregulation of 
this process results in hyperglycemia and T2D development (Weir and Bonner-Weir, 2004). 
Glucose-stimulated insulin secretion starts with the uptake of glucose by glucose 
transporter-2 (GLUT2) on the cell membrane. Then glucose is rapidly phosphorylated by 
glucokinase (Gck) to begin the glycolytic process. Glycolysis ends with the production of 
pyruvate, that enters the tricarboxylic acid (TCA) cycle in the mitochondria and gets converted 
to acetyl CoA. Acetyl CoA is ultimately oxidized to carbon dioxide. The electrons produced in 
the TCA cycle are used to generate ATP by oxidative phosphorylation in the mitochondria.  
The increased ATP/ADP ratio causes the closure of ATP-sensitive potassium channels leading 
to depolarization of plasma membrane which allows the opening of voltage-dependent calcium 
channels and the influx of calcium. Increased intracellular calcium causes the fusion of insulin 
granules to the plasma membrane and insulin exocytosis. While most studies focused on the 
dynamics of GSIS, it is worth investigating its underlying molecular mechanisms (reviewed in 
(Seino et al., 2011)). 
1.5 β cell maturation 
Newly differentiated fetal β cells are immature and have deficient physiological responses to 
glucose. These immature cells become functionally mature postnatally in the first 4 weeks after 
birth in rodents (Blum et al., 2012; Stolovich-Rain et al., 2015). During maturation, β cells 
undergo a number of metabolic and molecular changes. These changes define the β cell identity 
and β cell acquires GSIS feature.  
This transition from immature to mature β cell involves the increased expression of β 
cell-specific markers such as MafA, Urocortin3 (Ucn3), Gck and many other components that 
couple the metabolism of glucose to the insulin exocytotic machinery. MafA is recognized as 
a driver of β cell maturation where it specifically improves GSIS in immature β cells, likely 
through transcriptional regulation of a number of genes related to insulin secretion (Wang et 
al., 2007; Zhang et al., 2005). The others only serve as markers of β cell maturation such as 
Ucn3, a secreted protein in the corticotropin-releasing factor hormone family that is highly 
expressed in adult mouse and human β cells (Blum et al., 2012; van der Meulen et al., 2012). 
Ucn3 increases during maturation of mouse β cells as well as over the maturation of human 
stem cell-derived insulin-expressing cells (Blum et al., 2012; van der Meulen and Huising, 
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2014). Ucn3 injections enhance plasma levels of insulin in rats, but treatment with Ucn3 does 
not promote maturation of stem cell-derived insulin-expressing cells (Blum et al., 2012). 
Mature β cells are defined by not only the presence of maturity genes (described above) 
but also the repression of specific genes. Among these genes are the genes for high-affinity 
hexokinase 1 (HK1), monocarboxylate transporter 1 (MCT1) and lactate dehydrogenase A 
(LDHA). HK1 has high affinity for glucose and thus allows insulin secretion in response to 
low glucose and is replaced by the low affinity Gck during maturation, allowing only insulin 
secretion in response to higher glucose. MCT1 is a pyruvate transporter that feeds into the TCA 
cycle. Since lactate and pyruvate can be produced by other tissues such as muscle during 
exercise, repression of Mct1 (also named Slc16a1) in mature β cells prevents such metabolic 
interference that could otherwise promote insulin secretion in the absence of glucose (Pullen 
et al., 2012). Ldha repression further prevents conversion of exogenous lactate into pyruvate, 
which could similarly dysregulate insulin secretion (reviewed in (Liu and Hebrok, 2017). β cell 
maturation is illustrated in Figure 1.2. The molecular mechanisms that drive β cell maturation 
are not completely understood. 
 
Figure 1.2 Cartoon of β cell maturation 
Transition from immature to mature β cell involves the upregulation of: Mafa, Gck and Ucn3; 
and the down regulation of Slc16a1, Ldha, Hk1, Rest and Pdgfra. The number of insulin 
granules are increased too. 
1.6 Post-transcriptional regulation of β cell function 
In the past decade, miRNAs have attracted a great deal of research attention for post-
transcriptional regulation of gene expression in pancreatic β cells. miRNAs have been shown 
to regulate β cell development, differentiation, insulin biosynthesis, exocytosis and 
compensatory β cell expansion (Ozcan, 2015).  
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miRNAs are endogenously produced, short RNAs of 21–25 nucleotides (Bartel, 2009). 
miRNA synthesis starts initially by transcription of DNA by RNA polymerase II to relatively 
long primary transcripts with multiple hairpin loop structures called pri-miRNAs. These pri-
miRNAs are then processed by the RNase III enzyme “Drosha” to precursor miRNAs (pre-
miRNAs) of ~61 nucleotides. Finally, pre-miRNAs are exported to the cytoplasm where they 
are further processed into mature miRNA duplexes ~21-25 nucleotides in length by the type 
III RNase enzyme, Dicer. Dicer then transfers a single mature miRNA strand to the miRNA-
induced silencing complex (miRISC) that typically comprises Argonaute (Ago) family proteins 
(Kim et al., 2009). miRNA binds to the 3’UTR of its target gene through complementary base 
pairing. Ago2, a member of the Ago protein family interacts with an mRNA-binding protein, 
GW182, causing miRNA-induced mRNA gene silencing through translation repression and 
mRNA degradation (Braun et al., 2013; Fabian et al., 2011).  
Studies on mice revealed many miRNAs that are enriched in the β cell and play critical 
roles in modulating its physiology (Poy et al., 2004; Tattikota et al., 2015). Studies with β cell 
specific deletions of Dicer and Ago2 in mice demonstrated the important regulatory function 
of miRNAs in β cell function. Such studies spanned from investigating their role in the 
development of endocrine pancreas to the adult differentiated β cell. Dicer is found to be 
essential for the development of the endocrine pancreas and insulin biosynthesis and exocytosis 
in the adult β cell (Lynn et al., 2007; Martinez-Sanchez et al., 2015; Melkman-Zehavi et al., 
2011). miRNA inactivation by Dicer deletion in adult pancreatic β cells resulted in a striking 
diabetic phenotype in mice due to diminished insulin synthesis. Mechanistically, miRNAs in 
the adult β cell are found to be important for insulin expression through down regulating insulin 
transcriptional repressors such as Bhlhe22 and Sox6 (Melkman-Zehavi et al., 2011). However, 
Martinez-Sanchez et al. (2015) further showed that Dicer deletion caused β cell death following 
a decrease in GSIS was due to the upregulation of three disallowed genes that are direct targets 
for miRNAs. β cell disallowed genes are a group of genes that are normally abundantly 
expressed in most tissues and selectively repressed in β cells (Lemaire et al., 2016; Pullen and 
Rutter, 2013). The miRNA regulatory network is found to be equally important in another 
aspect of adult β cell function - compensatory β cell expansion. miRNA-184 is down regulated 
in the β cells of obese mice leading to upregulation of Ago2. Ago2 is shown to be required for 
insulin secretion and β cell compensatory expansion (Tattikota et al., 2014; Tattikota et al., 
2013). Tattikota et al. (2014) have shown that miRNA-184 is a unique miRNA that is down 
regulated during insulin resistance. This causes the upregulation of its target Ago2. Ago2, a 
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critical player in miRISC, causes silencing of the targets of another miRNA, miRNA-375, 
leading to compensatory β cell expansion. Further studies have implicated specific miRNAs in 
affecting insulin production (Setyowati Karolina et al., 2013; Zhang et al., 2011), exocytosis 
(Lovis et al., 2008a; Tattikota et al., 2015), or β cell apoptosis (Lovis et al., 2008b; Ruan et al., 
2011). 
Understanding post-transcriptional control of gene expression by miRNAs is 
complicated because a single miRNA can have several target mRNAs, and several miRNAs 
can work synergistically to affect the translation of a single mRNA. Deregulated expression of 
some miRNAs is involved in β cell dysfunction and the development of diabetes. Moreover, 
the expression of some miRNAs changes in response to metabolic demand as a compensatory 
response to allow for β cell proliferation and enhancement of insulin secretion (Guay and 
Regazzi, 2015; Nesca et al., 2013; van de Bunt et al., 2013).  
1.7 The CCR4-NOT complex: Definition, Structure and function 
Maintaining correct levels of mRNA expression requires the balance between mRNA synthesis 
and decay. Deregulation of mRNA decay can lead to the aberrant accumulation of mRNAs and 
the proteins they encode. mRNA decay begins with shortening of the poly(A) tail. 
Deadenylation is considered the rate limiting step of mRNA decay and is catalyzed by two 
main deadenylase complexes: the poly(A)-nuclease deadenylation complex (PAN2/3) and the 
CCR4-NOT complex (Chen and Shyu, 2011).  
The CCR4-NOT complex is a multi-meric complex of more than 2MDa size that is 
highly conserved in eukaryotes. Deadenylation activity of the CCR4-NOT complex was first 
identified in yeast (Tucker et al., 2001). In yeast, it consists of nine subunits (Ccr4, Caf1, Caf40, 
Caf130, Not1-5), and in mammals it consists of eight subunits (CNOT1, CNOT2, CNOT3, 
either CNOT7 or CNOT8, either CNOT6 or CNOT6L, CNOT9, CNOT10 and CNOT11) 
(Bartlam and Yamamoto, 2010; Collart, 2016; Collart and Panasenko, 2012). Although it is 
particularly highlighted as a major deadenylase that is essential for mRNA decay, CCR4-NOT 
is rather multifunctional and has been implicated in different aspects of RNA and protein 
expression which places CCR4-NOT as a core molecule in regulation of gene expression 
(Villanyi and Collart, 2015). Its diverse functions include regulation of transcription, 
transcription elongation, mRNA export, translational repression, chromatin modification, 
ubiquitination and protein modification (Collart, 2016; Collart and Panasenko, 2012; Miller 
Chapter 1                                                                                                                                                               8 
 
 
and Reese, 2012). Subunits of the CCR4–NOT complex have been found in both the nucleus 
and cytoplasm (Shi and Nelson, 2005; Tucker et al., 2002), which supports the involvement of 
the complex in both nuclear and cytoplasmic functions. However, it has not been determined 
whether the CCR4–NOT complex as an entity exists in both cellular compartments. The 
structure and function of CCR4-NOT complex are illustrated in Figure 1.3. 
 
Figure 1.3 Schematic representation of the CCR4-NOT complex structure and function 
(Collart and Panasenko, 2012) 
Mammalian CCR4-NOT complex subunits are classified as four catalytic and at least 
six non-catalytic subunits. The catalytic subunits comprise two exonuclease-endonuclease-
phosphatase (EEP) family proteins (CNOT6 and CNOT6L), and two DEDD (Asp-Glu-Asp-
Asp) family proteins (CNOT7 and CNOT8) which are orthologs of yeast Ccr4 and Caf1, 
respectively, while the non-catalytic subunits include CNOT1, CNOT2, CNOT3, CNOT9, 
CNOT10 and CNOT11 (Bawankar et al., 2013; Boland et al., 2013; Lau et al., 2009; Raisch et 
al., 2019). Mammalian CNOT3 was suggested to be the functional homologue of the yeast 
Not5 (Collart, 2016). The mammalian CCR4-NOT complex subunits and their corresponding 
yeast CCR4-NOT complex subunits are summarized in Table 1.  
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Table 1: Yeast and mammalian CCR4-NOT complex subunits 
Yeast CCR4-NOT complex Mammalian CCR4-NOT complex 
Not1 CNOT1 
Not2 CNOT2 
Not3  
Not4 CNOT4 (not stably associated with the 
complex (Lau et al., 2009)) 
Not5 CNOT3 
Ccr4 CNOT6/6L 
Caf1 CNOT7/8 
Caf40 CNOT9 
Caf130  
 CNOT10 
 CNOT11 
Despite the association of all of the subunits in a single complex, each subunit has a 
very specific role in gene expression (Azzouz et al., 2009). Regarding deadenylation function, 
only the catalytic subunits clearly contribute to mRNA deadenylation, but various different 
other subunits act as modulators of deadenylase activity and are important for recruitment of 
the CCR4-NOT complex to specific mRNAs (Bawankar et al., 2013; Boland et al., 2013; Chen 
et al., 2014; Ito et al., 2011a; Ito et al., 2011b; Morita et al., 2011; Petit et al., 2012; Raisch et 
al., 2019). Of note, CCR4-NOT is more active and selective for poly(A) than the isolated 
catalytic subunits. The catalytic subunits require at least two out of three conserved non-
catalytic modules (CNOT9, CNOT10/CNOT11 or CNOT2/CNOT3) for full activity in CCR4-
NOT complex (Raisch et al., 2019).  
Structural analyses revealed that CNOT1 is the largest subunit and is responsible for 
the assembly of the complex components. The CNOT2-CNOT3 heterodimer binds to C-
terminus of CNOT1 (Basquin et al., 2012; Boland et al., 2013; Petit et al., 2012).  Although the 
four catalytic subunits are all associated with the CCR4-NOT complex, only one subunit of 
EEP family and one subunit of DEDD family deadenylase exist in a particular complex (Lau 
et al., 2009). While CNOT1 binds directly to CNOT7/8 through its MIF4G domain (Bartlam 
and Yamamoto, 2010; Basquin et al., 2012; Petit et al., 2012), CNOT7/8 subunits are important 
for the association of CNOT6/6L subunits to the complex through protein-protein interaction 
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of CNOT7/8 with leucine rich repeat (LRR) domain of CNOT6/6L (Clark et al., 2004). When 
CNOT1 is suppressed in HeLa cells, most other subunits also decrease, resulting in severe 
reduction of deadenylase activity (Ito et al., 2011b). Therefore, CNOT1 is critical not only for 
assembly, but also for maintenance of the CCR4–NOT complex subunits expression. Similarly, 
CNOT3 contributes to complex stability, activity and recruits CCR4-NOT to target genes 
(Boland et al., 2013; Chicoine et al., 2007). Thus, deficiency of CNOT3 in mice affects stability 
of some mRNAs due to poor recruitment of the CCR4-NOT complex to the mRNA 3’UTRs 
(Chicoine et al., 2007; Morita et al., 2011; Suzuki et al., 2019; Suzuki et al., 2015; Watanabe 
et al., 2014). Knockout (KO) of Cnot3 is embryonically lethal in mice and causes necroptosis 
of mouse embryonic fibroblasts (MEFs) (Morita et al., 2011; Suzuki et al., 2015). These studies 
provide an evidence of the importance of CNOT3 in the CCR4-NOT complex deadenylase 
activity.  
1.8 Role of the CCR4-NOT complex in post-transcriptional regulation 
The main function of the CCR4-NOT complex is mRNA deadenylation. The deadenylation 
process occurs via two distinct steps (Chen and Shyu, 2011). In the first step, PAN2/3 catalyzes 
mRNA deadenylation and shortens poly(A) tail to approximately 110 nucleotides. This step 
doesn’t trigger mRNA decay as cytoplasmic poly(A) adenylases can still bind and add 
adenosine residues, extending the tail. In the second phase, CCR4-NOT catalyzes shortening 
of the 3′ poly(A) tail to variable lengths of 20~110 nucleotides which reduces the binding of 
poly(A) tail binding proteins, leading to a reduction in the rate of translation. As a result, the 
Dcp1/Dcp2 decapping complex is recruited and removes the 5’ cap structure of target mRNAs 
followed by rapid 5’ to 3’ degradation by the exoribonuclease, Xrn1. Alternatively, mRNAs 
are degraded from 3’ to 5’ by the exosome (Parker, 2012; Parker and Song, 2004). Both 3’ to 
5’ and 5’ to 3’ decay processes can occur together on the same mRNA molecule. CCR4-NOT 
complex is directed to specific mRNAs through association with RNA-binding proteins (RBPs) 
that bind directly to the 3’UTR of target mRNAs (Inada and Makino, 2014; Lykke-Andersen 
and Wagner, 2005; Semotok et al., 2005) and by miRNAs (Fabian et al., 2009; Wahle and 
Winkler, 2013) (See further in Figure 1.4).  
Several RBPs have been shown to mediate the interaction between CCR4-NOT 
complex subunits and particular target mRNAs. These RBPs recognize cis-acting elements 
within the mRNA 3’UTRs (Brennan and Steitz, 2001). AU-rich elements (ARE) in the 3’UTR 
are one of the well-characterized cis-acting elements that signals mRNA decay (Brennan and 
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Steitz, 2001). Tristetraprolin (TTP) family proteins such as BRF1 are among those RBPs, that 
recruit the CCR4-NOT complex, through interaction with ARE (Fabian et al., 2013; Takahashi 
et al., 2015; Wahle and Winkler, 2013). Other identified RBPs are: BTG/Tob family, Roquin, 
and Nanos2 (Bhandari et al., 2014; Leppek et al., 2013; Suzuki et al., 2010). CNOT1 is known 
to interact with TTP (Sandler et al., 2011). CNOT3 may also interact with Roquin thus 
recruiting CCR4-NOT complex to specific targets (Murakawa et al., 2015).   
 
Figure 1.4 Schematic illustration of recruitment of CCR4-NOT complex to its target 
mRNAs 
A complete description is provided in the main text (Figure adapted from (Ashworth et al., 
2019) 
Current evidence suggests that miRNA-mediated gene silencing requires direct 
interaction between GW182 and CCR4-NOT via CNOT1. Further structural studies showed 
the involvement of another subunit of CCR4-NOT complex, CNOT9, in inducing gene 
silencing by miRNA. CNOT9 attaches to a domain of unknown function (DUF3819) in 
CNOT1 resulting in a complex that provides binding sites for GW182. Furthermore, CNOT1 
interacts with DDX6, a known translational inhibitor (Chen et al., 2014; Rouya et al., 2014). 
The role of the CCR4-NOT complex in miRNA-mediated gene repression is supported by an 
increasing number of studies. One study showed that miRNA-dependent deadenylation is 
suppressed in CNOT1-depleted Drosophila melanogaster cells (Behm-Ansmant et al., 2006) 
and another study showed that miRNA-induced deadenylation in mouse was slowed down in 
cells overexpressing a dominant negative (DN) CNOT7 (Chen et al., 2009). Additionally, it 
was demonstrated that about 60% of Ago targets in Drosophila melanogaster are regulated by 
CNOT1 and/or CNOT7, and that 45% require both, suggesting that deadenylation is a 
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widespread effect of miRNA regulation (Eulalio et al., 2009). More recently, CNOT2 was 
found necessary for miRNA-mediated gene silencing in Drosophila development (Knox et al., 
2016). However, to what extent deadenylation contributes to miRNA-mediated repression is 
still under debate (Doidge et al., 2012).  
1.9 Multifunctional roles of CCR4-NOT complex in mammals 
The physiological significance of CCR4-NOT complex in mammals has been addressed by 
examining the phenotypes of conventional KO mice. Accumulating evidence suggests that 
each subunit, both catalytic and non-catalytic, plays an important physiological role (Shirai et 
al., 2014). The embryonic lethal phenotype occurring as a result of deletion of specific subunits 
(Cnot1, Cnot3, Cnot8, Cnot9 and Cnot10) hampered the use of these mouse mutants for 
assessment of specific subunits functions in organs and tissues. To circumvent this obstacle, 
conditional KO of a specific subunit in a specific organ or tissue is valuable for functional 
analysis. 
Although CCR4-NOT subunits are ubiquitously expressed (Chen et al., 2011a), it is 
evident that specific subunits regulate distinct biological processes. Targeted deletions of 
specific subunits of CCR4-NOT complex enabled the identification of their specific roles in 
the regulation of specific physiological processes. Thus, disruption of specific subunit could 
be relevant to specific disease (Doidge et al., 2012). Indeed, the CCR4–NOT complex has been 
implicated in the development of metabolic disorders. Cnot3 heterozygous (het), Cnot6l KO 
and Cnot7 KO mice are lean and display resistance to high-fat diet (HFD) induced obesity 
(Morita et al., 2011; Morita et al., 2019; Takahashi et al., 2015). Conditional Cnot3 or Cnot1 
KO in mice adipose tissue is associated with lipodystrophy and hyperlipidemia (Li et al., 2017; 
Takahashi et al., 2019). Cnot3 KO in heart is associated with autophagy and heart failure 
(Yamaguchi et al., 2018). Cnot3 KO in liver is associated with inflammation and the increased 
expression immature genes expression (Suzuki et al., 2019). Cnot7 KO mice have defects in 
spermatogenesis (Berthet et al., 2004). Accordingly, unraveling physiological roles of CCR4-
NOT complex would be a novel approach to elucidate disease pathogenesis and develop new 
therapeutics. 
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1.10 Problem statement and thesis aims 
Diabetes is one of the greatest healthcare challenges in the 21st Century. The number of diabetic 
patients continues to rise because how diabetes develops is not completely understood. Loss of 
β cell identity and dedifferentiation are recognized as mechanisms of β cell dysfunction in 
diabetes. Published evidence suggests that the CCR4-NOT complex regulates metabolism-
related genes via mRNA decay and may be involved in metabolic disorders such as obesity, 
lipodystrophy and diabetes.  Therefore, I hypothesize that the CCR4-NOT complex post-
transcriptionally regulates mRNAs governing β cell function and dysregulation of its 
expression or activity contributes to diabetes pathogenesis. 
The main goal of this thesis was to address the function of CCR4-NOT complex in 
pancreatic β cells and to understand the molecular mechanism of its function. A secondary goal 
was to elucidate the contribution of the CCR4-NOT complex catalytic subunits in mRNA decay 
and cell viability in MEFs.  
In Chapter two, the objective was to study the role of CNOT3 in pancreatic β cell 
function in mice. The approach was to delete CNOT3 specifically in β cells and to examine the 
phenotype of the mice. The function of the islets of Langerhans from mice with β cell-specific 
Cnot3 KO was evaluated in vitro. Following this, I performed RNA sequencing (RNA-seq) 
with the purpose of checking the effect of CNOT3 KO on global gene expression in β cells and 
identifying CNOT3 molecular targets. Being able to unravel previously unknown molecular 
mechanisms governing β cell function should ultimately contribute to the generation of 
functionally mature β cells in vitro or revert dysfunctional β cells to normal. 
In Chapter three, the objective was to compare the two types of CCR4-NOT complex 
deadenylase subunits: Ccr4-type (CNOT6/6L) and Caf1-type (CNOT7/8) with respect to 
mRNA deadenylation and cell survival in mammalian cells under normal physiological 
conditions. The approach was to delete the catalytic subunits in MEFs and to characterize the 
phenotype of mutant MEFs in terms of CCR4-NOT complex formation, cell survival, global 
mRNA deadenylation, global gene expression and mRNA stability. 
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 Chapter 2: CNOT3 is essential for β cell maturation and maintaining β cell identity 
2.1 Introduction 
Diabetes mellitus is a metabolic disorder that is ultimately caused by the loss of functional 
pancreatic β cells (Ashcroft and Rorsman, 2012), the only cells within the body that secrete 
insulin to regulate blood glucose homeostasis. Whilst T1D involves immune-mediated β cell 
destruction (Ashcroft and Rorsman, 2012), dedifferentiation and dysfunction, rather than β cell 
loss per se, is implicated in the pathogenesis of T2D (Talchai et al., 2012). A fuller 
understanding of the molecular mechanisms that govern β cell differentiation in utero, 
maturation after birth, and dedifferentiation in diabetes is likely to be crucial for developing 
novel prevention and treatment strategies for diabetes.  
Pancreatic β cells are defined functionally by the capacity for glucose- (and other 
nutrient-) stimulated insulin secretion (Rutter, 2004; Rutter et al., 2015). Underlying this is a 
molecular identity defined by the expression of genes that drive β cell maturation, insulin gene 
expression, insulin granule formation and exocytosis. Although extensive research has focused 
on the transcriptional and epigenetic regulation of β cell maturation, the influence of post-
transcriptional mechanisms on the β cell gene expression program is relatively less well defined. 
Nonetheless, glucose is known to stimulate the biosynthesis of insulin and a number of other β 
cell proteins, particularly those involved in insulin granule biogenesis, from pre-existing 
mRNAs (Magro and Solimena, 2013; Wicksteed et al., 2003). In addition, several studies 
(Baroukh et al., 2007; Latreille et al., 2014; Martinez-Sanchez et al., 2015; Nathan et al., 2015; 
Poy et al., 2004) have implicated non-coding RNAs: long non-coding RNAs (lncRNAs), and 
miRNAs as important modulators of β cell gene expression and function (Guay et al., 2012; 
Martinez-Sanchez et al., 2017). 
Most eukaryotic mRNAs are polyadenylated, and poly(A) tail lengths are important for 
post-transcriptional gene regulation (Eckmann et al., 2011; Nousch et al., 2013). Importantly, 
mRNA deadenylation is the rate-limiting step in mRNA decay (Garneau et al., 2007). 
Deadenylation involves shortening of poly(A) tail length, reducing the binding of poly(A) tail-
binding proteins. This decreases mRNA stability, slowing down translation (Eckmann et al., 
2011; Nousch et al., 2013).  
In this chapter I investigated whether and how mRNA deadenylation by CCR4-NOT 
complex regulates β cell function. Earlier studies revealed the involvement of the CCR4–NOT 
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complex in the development of metabolic disorders such as obesity, diabetes and lipodystrophy 
(Li et al., 2017; Morita et al., 2011; Takahashi et al., 2019). However, its role in maintaining 
normal β cell function has not been investigated. I focused on the CNOT3 subunit and 
presented evidence that CNOT3-dependent deadenylation serves as a post-transcriptional 
regulatory mechanism governing normal β cell function.  
2.2 Materials and Methods 
2.2.1 Mice 
To suppress Cnot3 expression in β cells, I crossed mice carrying Cnot3 floxed alleles 
(Cnot3flox/flox) (Inoue et al., 2015; Li et al., 2017) with Ins1-Cre mice (Riken Bioresource Center, 
# RBRC09525), in which Cre recombinase is knocked in at the Ins1 locus (Hasegawa et al., 
2016). Recombination is expected to be restricted largely to β cells, and to be minimal at other 
sites, including the brain, where Ins1 is not expressed (Thorens et al., 2015).  mTmG reporter 
mice (Jackson Laboratory, # 007676) were used to trace β cells in which Ins1-Cre-mediated 
recombination was induced (Muzumdar et al., 2007). β cell-specific Cnot3 knockout mice 
(Cnot3βKO) were used for experiments and their littermates (Cnot3flox/flox) were used as 
controls, unless stated otherwise (Ins1-Cre mice were used as controls for Cnot3βKO 
expressing the mTmG reporter gene). All experiments were performed on 8-10-week-old male 
mice, unless stated otherwise. db/db mice were used as a model of T2D (Kobayashi et al., 2000) 
and compared with +/db mice (Jackson Laboratory, #000697; purchased from CLEA Japan). 
Mice were maintained on a 12-hr light/12-hr dark cycle in a temperature-controlled (22° C) 
barrier facility with free access to water and either a normal chow diet (NCD, CA-1, CLEA 
Japan) or a HFD (D12492, Research diets). All mouse experiments were approved by the 
Animal Care and Use Committee in OIST Graduate University. 
2.2.2 Genotyping 
Tails from 3-week-old mice were lysed in 50 µL of DNA extraction lysis buffer (25mM NaOH, 
0.2 mM EDTA) 20 min in 100° C followed by addition of 50 µL of 40 mM Tris-HCl. Samples 
were then vortexed. 1 µL of lysed tail samples was used as template for PCR amplification as 
follows. All genotyping primers are listed in Table 3. 
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PCR mixture: 
• 0.4 µL of 10 µM of primers (Forward and Reverse primers)  
• 2 µL of 10 ExTaq buffer  
• 2 µL of 2.5 mM dNTP  
• 0.1 µL of ExTaq  
• 1 µL of template DNA 
• 14.5 µL of double distilled water  
PCR amplification of genomic DNA by cycling for 40 cycles:  
• Initial denaturation: 2 min at 95° C, 
• 45 s at 95° C, 
• 45 s at 60° C,  
• 1 min at 72° C.  
• Final extension: 5 min at 72° C. 
PCR products were run on 2% agarose gel with 10x loading sample buffer. 
2.2.3 Islet isolation 
Mouse pancreatic islets were isolated as previously described (Graham et al., 2016). Pancreata 
were perfused with Collagenase P (Sigma) by injection in the common hepatic bile duct at a 
concentration of 1 mg/mL in Hank’s buffered salt solution (HBSS) medium (Invitrogen) 
supplemented with 1% bovine serum albumin (BSA) (Roche).  Pancreata were then removed 
and dissociated in a 37° C water bath for 16 min. Dissociated pancreata were passed through a 
metal sieve to remove undigested tissue chunks, followed by washing in HBSS supplemented 
with 0.1% BSA. Islets were then separated onto a gradient of Histopaque 1077 (Sigma) 
overlaid with RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin-streptomycin (10,000 U/mL, Gibco). Afterward, islets were collected from 
the boundary of Histopaque 1077 and RPMI 1640 medium and passed through a 70 μm cell 
strainer (BD Falcon) into a cell culture dish with RPMI 1640 supplemented with 10% FBS and 
1% penicillin/streptomycin from which the islets were hand-picked for experiments to avoid 
contamination with exocrine tissue.  
 
40 cycles 
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2.2.4 Cell lines 
MIN6 (mouse insulinoma-6) β cell line, a well-established model for the study of the β-cell 
function, was used for some in vitro investigations (Miyazaki et al., 1990). MIN6 cells were 
cultured in high glucose Dulbecco’s modified Eagle’s medium (Wako) supplemented with 10% 
FBS and 1% penicillin-streptomycin (10,000 U/mL, Gibco). For induction of gluco-toxic stress, 
glucose concentration was increased to 50 mM by dissolving glucose in culture medium 
followed by sterile filtration. 
2.2.5 Fatty acid solution preparation and MIN6 cells treatment 
Palmitate stock solution was prepared by dissolving palmitate (Sigma P9767) in 50% ethanol 
at 70° C to a final concentration of 100 mM. The stock solution was then diluted in culture 
medium with 0.5% BSA to a final concentration of 0.5 mM. The palmitate was allowed to 
complex with the BSA for 30 min at 37° C before being added to the cells. Palmitate untreated 
cells were treated in the same manner, but palmitate stock solution was replaced with vehicle 
(50% ethanol). 
2.2.6 Immunoblot analysis 
Pancreatic islets and MIN6 cells were lysed using TNE lysis buffer (1% NP-40, 50 mM Tris–
HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonylfluoride, 10 mM NaF). 
Protein was quantified by Bicinchoninic acid (BCA) assay kit (Thermofisher) following the 
manufacturer’s protocol. All immunoblot analyses were done following SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) standard protocols except for MCT1 and LDHA, which were 
not detected by conventional Western blotting and so the automated Simple Wes system 
(ProteinSimple) was used for their detection (Harris, 2015).  
Immunoblot analysis following SDS-PAGE standard protocols:  
In brief, protein samples, adjusted to equal protein amounts and reduced by boiling with sample 
buffer, were resolved on a 10% polyacrylamide gel. Afterwards, proteins separated on the SDS-
PAGE were electro-transferred onto 0.45 m methanol activated polyvinylidene fluoride 
(PVDF) membrane at 17V for 70 min using semi-dry transfer system (Biocraft, cat. no. BE-
321). PVDF membrane was then blocked in 5% skimmed milk for 1 hr and probed with primary 
antibodies for overnight at 4° C. Eventually, the blots were visualized using a horseradish 
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peroxidase (HRP)-conjugated secondary antibody and Western Lightning Plus-ECL enhanced 
chemiluminescence substrate (PerkinElmer). Blots were imaged using an ImageQuant LAS 
4000 mini (GE Healthcare, Tokyo). Protein levels were quantified using ImageJ software and 
normalized to GAPDH protein levels. Buffers used for SDS-PAGE are listed in Appendix p. 
108- 110. 
Immunoblot analysis using automated Simple Wes system: 
I used an automated Simple Wes system according to the manufacturer’s instructions with a 
12–230 kDa Separation Module (ProteinSimple SM-W004) and the Anti-Rabbit Detection 
Module. In brief, 4 µL islet lysates were combined with 1µL Fluorescent Master Mix and 
heated at 95° C for 5 min. The biotinylated ladder, samples, antibody diluent, primary 
antibodies (in antibody diluent), HRP-conjugated secondary antibodies and chemiluminescent 
substrate were pipetted into the plate (part of Separation Module). Instrument default settings 
were used: stacking and separation at 375 V for 25 min; blocking reagent for 5 min, primary 
and secondary antibody both for 30 min; luminol/peroxide chemiluminescence detection for 
~15 min. Details of primary and secondary antibodies used are listed in Table 4 and Table 5 
respectively. 
2.2.7 Glucose tolerance tests 
Mice were fasted for 16 hrs starting from 19:00, immediately before the onset of the dark phase, 
followed by fasting blood glucose measurement in tail vein blood samples. Mice were then 
injected intraperitoneally with 2 g glucose per kg body weight and blood glucose was measured 
in tail vein blood samples at 15, 30, 60 and 90 min using the Glutest Pro glucometer (Sanwa 
Kagaku Kenkyusho, Japan). 
2.2.8 Glucose-stimulated insulin secretion assay in vivo 
Mice were fasted for 16 hrs, followed by blood sample collection from the face vein to evaluate 
serum insulin levels under no glucose stimulation. Mice were then injected intraperitoneally 
with 2 g glucose per kg body weight and blood samples were collected from the face vein 15 
min post- glucose injection. Blood samples were allowed to clot in vacutainer tubes (BD Japan) 
at room temperature followed by centrifugation for 10 min at 4000 rpm and separation of clear 
serum. Serum insulin levels were measured using an ultrasensitive mouse insulin ELISA kit 
(Takara).   
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2.2.9 Glucose-stimulated insulin secretion assay on islets ex vivo 
Ten islets were pre-cultured in 450 µL Krebs Ringer buffer (KRB; 140 mM NaCl, 3.6 mM KCl, 
0.5 mM NaH2PO4, 2 mM NaHCO3, 1.5 mM CaCl2, 0.5 mM MgSO4, 10 mM HEPES) 
containing 3 mM glucose for 1 hr in opened Eppendorf tubes. Supernatants were discarded and 
replaced with 450 µL KRB containing 3 mM glucose for 1 hr. Supernatants were collected to 
measure basal insulin secretion. Islets were then treated with 450 µL KRB containing 17 mM 
glucose and supernatants were collected after 1 hr. Islets were finally treated with 1 mL 1.5% 
HCl in ethanol and homogenized by sonication three times (30 seconds on/off). Acid/ethanol 
lysates were then centrifuged. Supernatants were collected to measure insulin content and 
residual islet fragments were used for DNA extraction using NucleoSpin Tissue XS (Takara). 
Insulin in KRB supernatant (released insulin) and islet lysates (islet insulin content) was 
measured using an ultrasensitive mouse insulin ELISA kit (Takara). Both released insulin and 
islets insulin content were normalized to islets DNA content. 
2.2.10 Tissue preparation and immunohistochemistry 
All immunohistochemistry was performed on pancreatic sections from control and Cnot3βKO 
mice, except for CNOT3 immunofluorescence staining, which was performed on islets isolated 
from control and Cnot3βKO mice because the anti-CNOT3 antibody used worked only in 
isolated islets but showed non-specific signal in pancreatic sections. 
Preparation of pancreatic sections and immunohistochemistry:  
Mouse pancreata were processed for immunohistochemistry as previously described (Choi et 
al., 2014). Pancreata were fixed overnight in 4% paraformaldehyde (PFA) in phosphate-
buffered solution (Wako) at 4° C. They were then transferred to 70% ethanol and subsequently 
embedded in paraffin and sectioned at 3 μm. Some sections were stained with hematoxylin and 
eosin (H & E). Other sections were used for immunofluorescence. All sections for 
immunofluorescence underwent dewaxing with xylene and rehydration with ethanol (100%, 
95%, 70% and 50%) by incubation for 3 min at room temperature. Antigen retrieval was 
performed using 10 mM sodium citrate buffer, pH6, at 120° C in a pressure cooker for 10 min. 
After cooling down to room temperature, tissue sections were permeabilized in 0.1% Triton-X 
100 in phosphate-buffered saline (PBS) for 30 min, then blocked with blocking buffer (2% 
BSA solution in PBS and 0.05% Tween) for 30-60 min at room temperature. Samples were 
then incubated with primary antibodies overnight at 4° C. On the following day, samples were 
Chapter 2 20 
 
 
washed three times in PBS and incubated with secondary antibodies for 1-2 hrs under dark 
conditions at room temperature. Finally, samples were washed three times in PBS and mounted 
in Ultracruz hard-set mounting medium (Santa Cruz). Terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) assay was performed using In Situ Cell Death Detection Kit, 
TMR Red (Roche) following the manufacturer’s protocol.  
Immunofluorescence staining of CNOT3: 
Islets were fixed in 4% PFA in phosphate-buffered solution (Wako) for 10 min at room 
temperature. Then samples were washed twice in PBS for 5 min. Residual PFA was quenched 
by incubation with 100 mM glycine for 10 min at room temperature, followed by two washes 
with PBS. Islets were then permeabilized in 0.5% Triton X-100 for 5 min at room temperature 
and rinsed twice with PBS. Islets were blocked with blocking buffer and incubated with 
primary and secondary antibodies in the same manner as described for pancreatic sections. 
Finally, samples were incubated with Ultra Cruz hard-set mounting medium with DAPI (Santa 
Cruz). Details of primary and secondary antibodies used for Immunofluorescence are listed in 
Table 6 and Table 7, respectively. 
2.2.11 Morphometric image analysis 
All immunohistochemistry/immunofluorescent images were acquired using a Leica confocal 
microscope (TCS SP8 Leica). All images were processed using ImageJ software. To calculate 
β cell mass, pancreatic sections were stained with anti-insulin antibody. Insulin stained area 
was taken as β cell area. Then β cell mass was calculated using the following equation:  
 β cell mass (mg) =
β cell area × pancreas weight (mg)
Pancreas area
 
2.2.12 Transmission electron microscopy 
Transmission electron microscopy (TEM) was performed as previously described (Masini et 
al., 2012). Islets were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 30 
min at room temperature. After three washes with 0.1M cacodylate buffer, islets were fixed in 
1% cacodylate-buffered osmium tetroxide for 1 hr at room temperature, then dehydrated in a 
graded ethanol series and embedded in epoxy resin. Ultrathin sections (50 nm) of islets were 
cut with a diamond knife (Diatome), placed on copper grids and stained with 4% uranium 
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acetate for 30 min and then with Sato’s lead staining solution. Samples were imaged using a 
JEOL JEM-1230R TEM. 
2.2.13 RNA extraction  
Total RNA was extracted from islets and MIN6 cells using Isogen II (Nippon Gene) according 
to the manufacturer’s protocol. RNA purity and concentration were evaluated by 
spectrophotometry using a NanoDrop ND-2000 (ThermoFisher) instrument. The quality of 
RNA was assessed using an Agilent 2100 Bioanalyzer microfluidics-based platform (Agilent 
Technologies, Inc.). 
2.2.14 Bulk poly(A) tail assay 
Total RNA (2 µg) was labelled with [5′-32P] pCp (cytidine 3′,5′-bis[phosphate]) (0.11 pmol/L 
in a total reaction volume of 30 L) (PerkinElmer; NEG019A) using T4 RNA ligase 1 (NEB, 
M0204S) at 16º C overnight. Labelled RNAs were incubated at 85º C for 5 min and placed on 
ice. Then, labelled RNAs were digested with Ribonuclease A (50 ng/L, Sigma) and 
Ribonuclease T1 (1.25 U/l, ThermoFisher Scientific) at 37º C for 2 hrs in digestion buffer 
(100 mM Tris-HCl [pH7.5], 3M NaCl, 0.5 g/mL yeast tRNA). The reaction was stopped by 
adding 5x stop solution (10 mg/mL Proteinase K, 0.125 M EDTA, 2.5% SDS) and 
subsequently incubating at 37º C for 30 min. After adding 400 L of RNA precipitation buffer 
(0.5 M NH4OAc, 10 mM EDTA), the digested RNA samples were purified by phenol-
chloroform extraction and isopropanol precipitation. Final products (10 L) were mixed with 
RNA Gel loading Dye (NEB, R0641) and incubated at 95º C for 2 min. Then, samples were 
fractionated on an 8 M urea-10% polyacrylamide denaturing gels (0.8 mm thick). Markers 
(Prestained Markers for small RNA Plus, BioDynamics Laboratory DM253) were also loaded. 
The gel was analysed with a Typhoon FLA 9500 Fluorescence Imager (GE Healthcare). Band 
intensity was quantified using ImageJ software. 
2.2.15 RNA sequencing 
RNA-seq was performed by the Next Generation Sequencing section at OIST Graduate 
University for three replicates (each prepared by pooling islets from two mice) per condition. 
100 ng of total RNA was used for RNA-seq library preparation with a TruSeq Stranded mRNA 
Library Prep Kit for NeoPrep (NP-202-1001; Illumina) that allows polyA-oligo(dT)-based 
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purification of mRNA, according to the manufacturer’s protocol with minor modification and 
optimization as follows. Custom dual index adaptors were ligated at the 5’ and 3’-ends of 
library, and PCR was performed for 11 cycles. 150 base-pair pair-end read RNA-seq was 
performed with a Hiseq 3000/4000 PE Cluster Kit (PE-410-1001; Illumina) and a Hiseq 
3000/4000 SBS Kit (300 Cycles) (FC-410-1003; Illumina) on Hiseq4000 (Illumina), according 
to the manufacturer’s protocol. 
2.2.16 Bioinformatic processing of RNA-seq data 
Paired-end RNA-seq data were mapped to the Mus musculus reference strain mm10 UCSC 
using, Strand NGS, next generation sequencing analysis software. Counts for each sample were 
imported into the R statistical environment. Genes without an expression level of at least one 
read per million mapped reads in at least three samples were removed before differential gene 
expression testing between control and Cnot3βKO islet RNA replicates, was performed with 
the edgeR function in the Bioconductor package edgeR (Robinson et al., 2010). Genes that 
were differentially expressed (DE) with a False Discovery Rate (FDR), adjusted P value less 
than 0.05 were considered statistically significant and included in enrichment testing. I 
identified Gene Ontology (GO) terms enriched among significantly upregulated and down 
regulated genes using DAVID annotation tool (https://david.ncifcrf.gov/). GO terms were 
considered significantly enriched if they had an FDR value of less than 0.05.  
2.2.17 mRNA stability measurement and qPCR 
To measure mRNA stability, islets were treated with actinomycin D (Act. D) (5 μg/mL), a 
transcription inhibitor, and total RNA was extracted at the indicated time points and subjected 
to qPCR. Total RNA (1 μg) was used for reverse transcription with oligo(dT)12-18primer 
(Invitrogen) using the SuperScript III First-Strand Synthesis System (Invitrogen). qPCR 
reactions were carried out using TB Green Premix Ex Taq (Takara) and ViiA 7 Real-Time PCR 
System (Applied Biosystems). Gapdh mRNA levels were used for normalization. Relative 
mRNA expression was determined by ∆∆Ct method. Primers used for qPCR reactions are listed 
in Table 8. 
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2.2.18 Sample preparation for proteomic analysis 
Samples were prepared for Liquid Chromatography/Mass Spectrometry (LC/MS) using the 
Phase-Transfer Surfactant Method (Masuda et al., 2009; Masuda et al., 2008), with minor 
modifications. First, proteins were extracted from islets and solubilized using buffer containing 
12 mM sodium deoxycholate, 12 mM sodium N-dodecanoylsarcosinate, and 100 mM Tris pH 
9.0, with EDTA-free Protease Inhibitor Cocktail (Roche, Switzerland). Islets were sonicated 
for 10 min using a Bioruptor (Cosmo Bio, Japan) on high power with 1-min on/1-min off cycles. 
Cell debris was removed after centrifugation at 18,000 x g for 20 min at 4°C. Protein 
concentrations were adjusted to a uniform concentration for a set of samples (0.5-1.0 μg/μL) 
and between 5-20 μg protein was used for peptide preparation. Cysteine-cysteine disulfide 
bonds were reduced with 10 mM dithiothreitol at 50° C for 30 min. Free thiol groups were 
alkylated with 40 mM iodoacetamide in the dark at room temperature for 30 min. Alkylation 
reactions were quenched with 55 mM cysteine at room temperature for 10 min. Samples were 
diluted with 2.76 volumes of 50 mM ammonium bicarbonate. Lysyl endopeptidase (Wako, 
Japan) and trypsin (Promega, USA) were added at a 50:1 ratio of sample protein:enzyme (w/w) 
and samples were digested for 14 hrs at 37° C. Afterward, 1.77 volumes ethyl acetate were 
added, and samples were acidified with trifluoroacetic acid (TFA), which was added to 0.46% 
(v/v). Following centrifugation at 12,000 x g for 5 min at room temperature, samples separated 
into two phases. The upper organic phase containing sodium deoxycholate was removed, while 
the lower aqueous phase containing digested tryptic peptides was dried using a centrifugal 
vacuum concentrator. Digested peptides were dissolved in 300 µL of 0.1% (v/v) TFA in 3% 
acetonitrile (v/v) and samples were desalted using MonoSpin C18 columns (GL Sciences Inc., 
Japan). Peptides were eluted from C18 columns using 0.1% TFA in 50% acetonitrile and dried 
in a vacuum concentrator. Tryptic peptides were dissolved in 0.1% (v/v) formic acid in 3% 
(v/v) acetonitrile for MS analysis.  
2.2.19 Mass spectrometry measurement 
Samples were measured using a Q-Exactive Plus Orbitrap LC-MS/MS System (Thermo Fisher 
Scientific, USA), equipped with a Nanospray Flex ion source. The same amount of peptide 
was injected for each sample, which was typically 300-600 ng in a volume of 2 to 5 µL. 
Peptides were separated on a 3-micrometer particle, 75 micrometer inner diameter, 12 cm 
filling length C18 column (Nikkyo Technos Co., Ltd., Japan). A flow rate of 300 nL/min was 
used with a two-hr gradient (1% to 34% solvent B in 108 min, 34%  to 95% solvent B in 2 min, 
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with a final wash at 95% solvent B for 10 min, where solvent A was 0.1% (v/v) formic acid in 
LC/MS grade water and solvent B was 0.1% (v/v) formic acid in 80% (v/v) acetonitrile). The 
mass spectrometer ion transfer tube temperature was 250° C and 2.0 kV spray voltage was 
applied during sample measurement.  
For data-dependent acquisition (DDA), full MS spectra were acquired from 380 to 1500 
m/z at a resolution of 70,000. The AGC target was set to 3e6 with a maximum injection time 
(IT) of 100 ms. MS2 scans were recorded for the top 20 precursors at 17,500 resolution with 
an AGC of 1e5 and a maximum IT of 60 ms. The first mass was fixed at 150 m/z. The default 
charge state for the MS2 was set to 2. HCD fragmentation was set to normalized collision 
energy of 27%. The intensity threshold was set to 1.3e4, charge states 2–5 were included and 
the dynamic exclusion was set to 20 s. 
For data-independent acquisition (DIA), data were acquired with 1 full MS and 32 
overlapping isolation windows constructed covering the precursor mass range of 400-1200 m/z. 
For full MS, resolution was set to 70,000. The AGC target was set to 5e6 and maximum IT was 
set to 120 ms. DIA segments were acquired at 35,000 resolution with an AGC target of 3e5 and 
an automatic maximum IT. The first mass was fixed at 150 m/z. HCD fragmentation was set 
to normalized collision energy of 27%.  
2.2.20 Protein identification and quantification 
Raw files from DDA measurement were searched against the Uniprot mouse database using 
Proteome Discoverer v2.2 software (Thermo Fisher Scientific, USA). Digestion enzyme 
specificity was set to Trypsin/P. Precursor and fragment mass tolerance were set to 10 ppm and 
0.02 Da, respectively. Modification included carbamidomethylation of cysteine as a fixed 
modification, with oxidation of methionine and acetyl (protein N-terminus) as variable 
modifications. Up to 2 missed cleavages were allowed. A decoy database was included to 
calculate the FDR. Search results were filtered with FDR 0.01 at both peptide and protein levels. 
The filtered output was used to generate a sample-specific spectral library using Spectronaut 
software (Biognosys, Switzerland). Raw files from DIA measurements were used for 
quantification data exaction with the generated spectral library. FDR was estimated with the 
mProphet approach (Reiter et al., 2011) and set to 0.01 at both peptide precursor level and 
protein level (Rosenberger et al., 2017). Data were filtered with FDR < 0.01 in at least half of 
the samples.  
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2.2.21 RNA immunoprecipitation 
RNA immunoprecipitation (RIP) was done on MIN6 cells using anti-CNOT3 antibody 
(generated by immunizing mice in cooperation with Bio Matrix Research Incorporation). 
MIN6 cells 80% confluent in 10-cm dishes were lysed with 1mL TNE buffer per dish. MIN6 
cell lysates were then incubated with 1µg of either anti-CNOT3 or control IgG antibody in an 
upside-down tumbling manner for 1 hr at 4° C, and then incubated with 40 μL of protein G 
Dynabeads (Invitrogen) in an upside-down tumbling manner for 2 hrs at 4° C. Later, beads 
were separated using a magnetic rack and washed 5 times with TNE buffer. RNAs in immune 
complexes were isolated using Isogen II, and cDNA was generated with SuperScript Reverse 
Transcriptase III followed by qPCR. The abundance of each mRNA is quantified as % of input 
mRNA then mRNA bound to anti-CNOT3 antibody was presented as fold change (FC) relative 
to mRNA bound to control IgG antibody. 
2.2.22 Preparation of Bait RNA and analysis of RBPs  
Total RNA was extracted from MIN6 cells as described above followed by reverse 
transcriptase reaction into cDNA. PCR reactions using Phusion high-fidelity DNA polymerase 
(New England Biolabs) were carried out to amplify mouse 3’UTRs of Slc16a1, Ldha, Wnt5b, 
and Abtb2 using cDNA as a template. Primers used for 3’UTR amplification are listed in Table 
9. PCR products were then ethanol precipitated and digested with Xba1 restriction enzyme. 
Afterward, 3’UTRs were inserted into the pGL3 control vector (Promega). 3’UTR sequences 
were verified by DNA sequencing. FLAG-tagged 3’UTRs bait RNA were generated by Dr. 
Shungo Adachi as described previously (Adachi and Natsume, 2015). 
For the identification of Slc16a1, Ldha, Wnt5b, and Abtb2 3′-UTRs binding proteins, 
lysates from MIN6 cells were incubated with 10 pmol FLAG-tagged 3′-UTRs bait RNA for 
1 hr at 4° C in an upside-down tumbling manner and then incubated with anti-FLAG M2 
antibody (Sigma, F1804) and Dynabeads (Invitrogen) for 2 hrs at 4° C in an upside-down 
tumbling manner. The bait RNA-protein complexes were eluted by FLAG-peptide elution. 
Dyna beads were incubated with 20 μL FLAG-peptide (1 mg/mL) for 30 min at room 
temperature with shaking every 10 min. Finally, bait RBPs were analyzed by immunoblot 
analysis as described in section 2.2.6. 
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For validating CNOT3 direct interaction with plausible RBPs, FLAG-tagged CNOT3 
construct was inserted into pcDNA vector and used for transfecting MIN6 using TransIT-LT1 
transfection reagent (Takara). Two days after transfection, cell lysates were prepared. 10% of 
each lysate was used for immunoblot analysis (Lysates). The rest of each lysate was treated 
with RNase (1µg/mL) and incubated with anti-FLAG M2 antibody (Sigma, F1804) and 
Dynabeads (Invitrogen) for 2 hrs at 4° C in an upside-down tumbling manner. Protein 
complexes were eluted by boiling in 1x sample buffer, and bait RBPs were analyzed by 
immunoblot analysis as described in section 2.2.6.  
2.2.23 Statistical Methods 
Differences between groups were examined for statistical significance using Student’s t-test 
(two-tailed distribution with two-sample equal variance). Analyses were performed using 
GraphPad Prism (GraphPad Software v.8.0), RStudio (v.1.1.453) and GSEA (v.4.0.1) 
developed by Broad Institute (http://software.broadinstitute.org/gsea/index.jsp). P value of 
<0.05 was considered statistically significant.  
2.3 Results 
2.3.1 Expression of CCR4–NOT complex subunits is deregulated in pancreatic islets in 
diabetes and obesity 
I first asked whether CCR4–NOT complex subunit expression is altered in the diabetic state. 
Accordingly, I isolated islets from the db/db mouse model, which lacks the leptin receptor and 
develops severe obesity associated with diabetes resembling human T2D (Burke et al., 2017; 
Kobayashi et al., 2000). Immunoblot analysis revealed a decrease in CCR4–NOT subunits 
CNOT1, CNOT2 and CNOT3 (Figure 2.1a), suggesting impaired deadenylase activity of the 
CCR4–NOT complex in diabetic islets. I also observed increased expression of CNOT8, one 
of the deadenylase subunits. To determine whether CCR4–NOT is a possible early effector in 
the pathogenesis of diabetes, I examined the expression of CCR4–NOT complex subunits in 
the prediabetic state as well using mice fed on HFD for three months starting at 8 weeks of age 
and examined at 20 weeks of age. Compared to db/db mice, none of the CCR4-NOT complex 
subunits showed deregulated expression except for CNOT8 that increased by HFD (Figure 
2.1b). To find out whether this effect on CCR4–NOT complex subunits was the result of gluco-
/lipo-toxicity, I analyzed CCR4–NOT subunit expression in MIN6 cells after chronic exposure 
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(1 week) to high glucose (50 mM) with or without palmitic acid (0.5 mM). Consistent with the 
observations in HFD-fed mice, only CNOT8 expression increased with palmitic acid treatment. 
On the other hand, glucotoxic stress didn’t show any obvious effect (Figure 2.1c).  
 
Figure 2.1  Deregulation of CCR4–NOT complex in models of diabetes and obesity 
(a-c) Immunoblot analysis of CCR4–NOT complex subunits in: (a) islet lysates from 16-week-
old +/db control and db/db mice (n=3). (b) islet lysates from 20-week-old normal diet (ND) 
and high-fat diet (HFD) fed mice (n=3). (c) MIN6 cells under low/high glucose conditions 
(LG/HG) with or without palmitic acid (PA) treatment. This HG/PA treatment experiment is a 
representative of three independent experiments. 
2.3.2 Loss of CNOT3 in β cells is associated with impaired CCR4–NOT complex 
deadenylase activity  
In the light of the above findings I sought to investigate the roles of the CCR4–NOT complex 
in pancreatic β cells, thus I generated Cnot3βKO mouse model lacking the Cnot3 gene in β 
cells. Successful suppression of CNOT3 in β cells was confirmed by immunoblot analysis and 
immunofluorescence (Figure 2.2a, b). Consistent with CNOT3 suppression effect on other 
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CCR4-NOT complex subunits in other tissues (Inoue et al., 2015; Suzuki et al., 2015; 
Yamaguchi et al., 2018), the abundance of other CCR4-NOT subunits decreased in Cnot3βKO 
islets (Figure 2.2a). Moreover, bulk poly(A) tail analysis showed that the population of poly(A) 
tail length with longer than 50 nucleotides increased in Cnot3βKO islets compared with 
controls (Figure 2.2c, d), indicating impairment of deadenylase activity.  
 
 
Figure 2.2 Disruption of CCR4–NOT complex deadenylase activity by loss of CNOT3 
(a) Immunoblot analysis showing decreased CNOT3 in islet lysates from 8-week-old 
Cnot3βKO compared with control mice (n=3). (b) Immunofluorescence staining showing 
CNOT3 (green) suppression as well as its cytosolic localization in islets from 8-week-old 
Cnot3βKO compared with control mice (n=2), DAPI (blue). (c) Poly(A) tail lengths of bulk 
RNA in Cnot3βKO compared with control islets (each sample is pooled from 4 mice).  
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Figure 2.2 (continued). (d) Densitograms of poly(A) tail lengths. Bulk poly (A) assay was 
conducted by Dr. Akiko Yanagiya. 
 
2.3.3 Loss of CNOT3 in β cells causes impaired glucose tolerance and insulin secretion 
To determine whether CNOT3 depletion affects β cell function, I first conducted glucose 
tolerance tests on 4-, 8- and 12-week-old mice to compare glucose metabolism between control 
and Cnot3βKO mice. At 4 weeks of age, Cnot3βKO mice showed glucose tolerance and fasting 
blood glucose levels comparable to those of control mice (Figure 2.3a). While fasting blood 
glucose levels were still similar between 8-week-old control and Cnot3βKO mice, Cnot3βKO 
mice showed impaired glucose tolerance (Figure 2.3b). By 12 weeks of age, Cnot3βKO mice 
developed overt diabetes indicated by significant elevation of fasting blood glucose levels and 
failure of glucose decrease after the injection (Figure 2.3c). With development of overt diabetes, 
12-week-old Cnot3βKO mice displayed a general deterioration of their health condition and 
clinical signs of diabetes, including polyuria, polydipsia (data not shown) and weight loss 
(Figure 2.3d). These results suggest that the metabolic impairment worsened with age 
supporting progressive loss of β cell function in Cnot3βKO mice. Indeed, blood glucose levels 
in 8-week-old Cnot3βKO mice were significantly elevated above those of control mice under 
normal feeding conditions (Figure 2.3e).  
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Figure 2.3 Loss of CNOT3 in β cells causes impaired glucose tolerance 
(a-c) Intraperitoneal glucose tolerance tests in: (a) 4-, (b) 8- and (c) 12- week-old control and 
Cnot3βKO male mice (n=6-9). (d) Body weight comparisons between control and Cnot3βKO 
male mice at 4-, 8- and 12- weeks of age (n=6-9). (e) Blood glucose measurements of 8-week-
old control (n=6) and Cnot3βKO (n=13) male mice fed ad-libitum. Data are presented as mean 
± standard error of the mean (S.E.M); * P < 0.05; ** P <0.01; *** P <0.001 
Furthermore, I measured fasting serum insulin levels and serum insulin levels after 
glucose administration in 8-week-old mice. There was no significant difference in fasting 
serum insulin levels between Cnot3βKO mice and control littermates. Yet, Cnot3βKO mice 
had a significantly lower serum insulin levels measured 15 min after glucose bolus 
administration compared with control littermates (Figure 2.4a). To evaluate β cell function, I 
assessed GSIS by islets isolated from 8-week-old Cnot3βKO mice and control littermates. 
Cnot3βKO islets displayed normal insulin secretion at low (3 mM) glucose but significantly 
decreased insulin secretion upon stimulation with high (17 mM) glucose compared with control 
islets (Figure 2.4b). This provides evidence for a functional impairment of Cnot3βKO islets. 
This ex vivo assay result also agrees with the observed normal fasting serum insulin levels in 
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Cnot3βKO mice and decreased serum insulin after in vivo glucose stimulation (shown in Figure 
2.4a).  
 
Figure 2.4 Loss of CNOT3 in β cells causes decreased GSIS 
(a) Serum insulin measured in 8-week-old control and Cnot3βKO male mice after 16 hrs 
fasting (0 min) and 15 min after injection of 2g/kg glucose (n=4). (b) Insulin released by islets 
from 8-week-old control and Cnot3βKO male mice in response to low 3mM glucose (3G) and 
high 17 mM glucose (17G) stimulation of 1 hr. This experiment is a representative of three 
independent experiments using three different biological replicates (n=3).  
Morphological evaluation of islets from 8-week-old Cnot3βKO mouse by H&E 
staining revealed pale nuclear staining with many islets showing abnormal shapes. At 12 weeks 
of age, almost all Cnot3βKO islets displayed abnormal shapes and neovascularization. At 20 
weeks of age, Cnot3βKO islets were hardly detected and the number of cells in individual islets 
was markedly reduced in a manner similar to that observed in diabetic Goto-Kakizaki rats 
(Momose et al., 2006) (Figure 2.5).  
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Figure 2.5 Cnot3βKO islets display abnormal morphology resembling diabetic islets 
H&E-stained pancreatic sections from 8-, 12- and 20-week-old control and Cnot3βKO mice.   
2.3.4 Cnot3βKO mice display reduced numbers of insulin-producing cells 
β cell-specific depletion of Cnot3 led to a significant reduction of the expression of murine 
insulin gene isoforms (Ins1 and Ins2) as shown in Figure 2.6a. Immunofluorescent staining of 
pancreatic sections revealed a loss of insulin expression in many β cells in Cnot3βKO islets 
(Figure 2.6b). This was associated with a significant reduction in insulin content in Cnot3βKO 
islets compared with control islets (Figure 2.6c). As expected, on quantifying β cell mass, there 
was a significant reduction in β cell mass by nearly 50% in Cnot3βKO mice (Figure 2.6d). This 
was not associated with a significant difference in islet number in Cnot3βKO mice compared 
with control mice (Figure 2.6e), but rather with the presence of smaller islets.  
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Figure 2.6 Lack of CNOT3 in β cells causes decreased insulin expression 
 (a) qPCR analysis of insulin mRNA isoforms (Ins1 and Ins2), normalized to the Gapdh mRNA 
level, in control and Cnot3βKO islets. (b) Immunofluorescence staining of insulin (red) and 
DAPI (blue) in pancreatic sections from 8-week-old control and Cnot3βKO male mice (n=4). 
(c) Insulin content of islets from 8-week-old control and Cnot3βKO mice (n=3). (d) β cell mass 
measurement in pancreatic sections from 8-week-old control and Cnot3βKO male mice (n=4). 
(e) Islet number per pancreas area in pancreatic sections from 8-week-old control and 
Cnot3βKO mice (n=4). Data are presented as mean ± S.E.M; * P < 0.05; ** P <0.01; *** P 
<0.001 
These findings prompted me to determine whether decreased pancreatic insulin content 
and reduced β cell mass were driven by increased β cell death. I examined β cell apoptosis by 
TUNEL assay. Cnot3βKO islets did not show extensive TUNEL staining compared with 
control islets, even though I observed few TUNEL-positive islet cells in Cnot3βKO mice, 
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suggesting that CNOT3 depletion compromises β cell viability to some extent (Figure 2.7a). 
Subsequent experiments focused on the majority of β cells that survived Cnot3 depletion, but 
lacked insulin expression. 
In order to trace Cnot3 depletion in β cells, I used an Ins1-Cre mTmG reporter mouse 
model in which the successfully recombined cells show green fluorescence from the expression 
of membrane- localized EGFP (mG) whereas unrecombined cells show red fluorescence of 
membrane- localized tdTomato (mT). Paraformaldehyde fixation masks mTmG fluorescence, 
so in order to trace successfully recombined cells I did immunofluorescence staining of EGFP. 
Immunofluorescence staining of insulin and EGFP in control mice expressing Cre recombinase 
(Control; +/Ins1-Cre) revealed successful labeling of β cells with EGFP. In 8-week-old 
Cnot3βKO islets, many EGFP-positive cells were insulin-negative and did not stain with anti-
GLUC, anti-SST and anti-PPT antibodies, indicating that β cells did not transform into other 
types of islet cells (Figure 2.7b). Furthermore, EGFP-positive cells in Cnot3βKO islets stained 
for the pan-endocrine marker, Synaptophysin (SYP), indicating that these hormone-negative 
cells are viable and retain their endocrine phenotype (Figure 2.7c).  
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Figure 2.7 Reduced β cell mass was not driven by β cell death 
(a) TUNEL assay performed on pancreatic sections from 8-week-old control and Cnot3βKO 
male mice, DAPI (blue), Insulin (red) and TUNEL (white).  
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Figure 2.7 (continued). (b) Co-immunofluorescence staining of EGFP (green), insulin (red), 
GLUC (blue), SST (blue) and PPT (blue) in pancreatic sections from 8-week-old mTmG 
reporter: “control (Cnot3+,+;+/Ins1-Cre) and Cnot3βKO” mice. (c) Co-immunofluorescence 
staining of EGFP (green), insulin (red) and SYP (blue) in pancreatic sections from 8-week-old 
mTmG reporter: “control (Cnot3+,+; +/Ins1-Cre) and Cnot3βKO” mice. 
 
2.3.5 CNOT3 KO affects insulin granule formation 
I further examined Cnot3βKO islets by TEM to detect any ultrastructural alterations in β cells. 
Control islets possessed β cells with typical insulin granules, bearing characteristic electron-
dense crystal cores, and with β cell-β cell contacts displaying tight junctions essential for 
normal insulin secretion (Benninger and Piston, 2014). In contrast, β cells from Cnot3βKO 
islets were rather heterogeneous in appearance, with few having typical insulin granules.  Many 
were degranulated with few, or abnormally small, insulin granules. Also observed in 
Cnot3βKO islets were β cells in which insulin granules were atypically rod-shaped, or with 
irregular plasma membranes (Figure 2.8a-d). Of note, despite observed ultrastructural changes, 
these β cells were viable (as evident from TUNEL assay results, see Figure 2.7a) and 
maintained their expression of SYP (Figure 2.7c).  The above findings suggest that diabetes in 
Cnot3βKO mice is caused by both lack of β cell functional identity and, possibly, failure to 
attain a fully differentiated state.  
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Figure 2.8 Lack of CNOT3 causes ultrastructural changes in β cells relevant to reduced 
GSIS 
(a-c) Transmission electron microscopy performed on islets isolated from 8-week-old control 
and Cnot3βKO mice (n=3), including quantification of (b) vesicle density, (c) vesicle diameter 
and (d) the percentage of mature (black bar) and immature vesicles (white bar). Data are 
presented as mean ± S.E.M; * P < 0.05; ** P <0.01; *** P <0.001. 
2.3.6 CNOT3 is essential for β cell maturation and identity 
Considering the above observations, my next goal was to investigate dedifferentiation 
as a possible factor contributing to reduced functional β cell mass. Therefore, I performed 
qPCR to measure expression of dedifferentiation/progenitor cell markers. I observed 
significant upregulation of β cell dedifferentiation/progenitor cell markers including Ngn3, 
Aldh1a3, Myt1, Dcx and Tnfrsf11b (Figure 2.9a). ALDH1A3 was recently recognized as a 
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marker of β cell dedifferentiation in diabetes (Cinti et al., 2016; Kim-Muller et al., 2016). 
Immunoblot analysis of ALDH1A3 revealed its significant upregulation in islets isolated from 
Cnot3βKO mice compared with control islets (Fig. 2.9b, c). This suggests that β cells in 
Cnot3βKO mice exhibits progenitor-like state. 
 
Figure 2.9 Cnot3βKO islets display increased expression of progenitor/ dedifferentiation 
markers 
(a) qPCR analysis of progenitor cells/dedifferentiation markers, normalized to the Gapdh 
mRNA level, in control and Cnot3βKO islets (n=4-6). (b) Immunoblot analysis of ALDH1A3 
in islet lysates from 8-week-old control and Cnot3βKO mice. (c) Band quantification of 
immunoblots of ALDH1A3 (n=3). 
In addition, I checked the expression of a number of genes critical for β cell function. 
Among the transcription factors important for β cell function and insulin transcription tested 
(Mafa, Nkx2.2, Nkx6.1, NeuroD1 and Pdx1), only Mafa mRNA was significantly reduced 
(Figure 2.10a).  Mafa, is a key β cell transcription factor and a driver of β cell maturation 
(Nishimura et al., 2015), that was reduced at the protein level as well (Figure 2.10e). In line 
with decreased GSIS, MS analysis revealed significant reductions in proteins involved in 
glucose sensing, insulin secretory granule maturation and insulin secretion (Table 2). Some of 
the affected proteins did not manifest altered mRNA levels or decreased but not significantly 
at the mRNA level (Figure 2.10a-d). I observed decreased expression of GLUT2 “encoded by 
Slc2a2 gene” in Cnot3βKO pancreata (Figure 2.10f). In support of defective maturation of 
CNOT3-depleted β cells, I found that Ucn3, a marker of β cell maturation, that is also reported 
to be important in GSIS (van der Meulen and Huising, 2014), was unchanged at the mRNA 
level yet was strongly decreased at the protein level (Figure 2.10d, Table 2). Moreover, 
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Cnot3βKO mice displayed a post-transcriptional defect in insulin biosynthesis where 
Cnot3βKO islets displayed a significant decrease in the expression of genes encoding proteins 
involved in insulin biosynthesis, such as T2D-associated zinc transporter Slc30a8, proinsulin-
to-insulin convertase (Pcsk2) “encoding PC1” and Cpe (Bellomo et al., 2011; Zito et al., 2010) 
(Figure 2.10c, d, Table 2). These proteins have established roles in insulin processing and/or 
maturation of insulin secretory granules. These data reveal loss of β cell maturation markers, 
defects in insulin granule formation and insulin biosynthesis. 
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Figure 2.10 Cnot3 KO causes reduced expression of β cell-specific genes 
(a-d) qPCR analysis of β cell-specific functional mRNAs expression categorized as: (a) β cell-
specific transcription factors, (b) glycolytic pathway, (c) insulin granules maturation and (d) 
insulin secretion mRNAs, normalized to the Gapdh mRNA level, in control and Cnot3βKO 
islets (n= 4-7). (e-f) Co-immunofluorescence staining of: (e) MAFA (green) and insulin (red), 
(f) GLUT2 (green) and insulin (red) in pancreatic sections from 8-week-old control and 
Cnot3βKO male mice (n=4). 
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In normal mature β cells, insulin secretion is regulated by coupling of glucose 
metabolism to insulin secretion (Prentki et al., 2013). Glucose first enters the β cell, undergoes 
glycolysis which is coupled to mitochondrial metabolism that increases the ATP/ADP ratio 
closing the potassium channels and opening the calcium channels that ultimately allows 
calcium influx and consequently insulin secretion (Rutter et al., 2015). Multiple genes involved 
in glycolysis are upregulated in diabetes and interfere with the normal insulin secretion 
(Haythorne et al., 2019). This prompted me to investigate mRNAs encoding glycolytic 
enzymes (Ldha, Hk1 and Hk2) alongside other mRNAs that are normally selectively repressed 
in mature β cells (Slc16a1/Mct1, Rest and Pdgfra) and loss of whose repression may result in 
impaired β cell function (Pullen et al., 2012). I observed significant upregulation of Slc16a1 
and Ldha, which belong to the β cell disallowed genes. Hk1, Hk2, Rest and Pdgfra were 
upregulated but the increases were not statistically significant (Figure 2.11a). I confirmed the 
upregulation of Slc16a1 protein (MCT1), LDHA and HK1 at the protein level as well (Figure 
2.11b, c, Table 2). These data support a metabolic phenotype resembling that of immature/fetal 
β cells. 
 
 
Figure 2.11 Cnot3βKO islets display increased expression of immature β cell markers 
(a) qPCR analysis of immature β cell markers, normalized to the Gapdh mRNA level, in control 
and Cnot3βKO islets (n=5-7). (b) Immunoblot analysis of MCT1 and LDHA in islet lysates 
from 8-week-old control and Cnot3βKO mice. (c) Band quantification of immunoblot of 
MCT1 and LDHA (n=3). Data are presented as mean ± S.E.M; * P < 0.05; ** P <0.01; *** P 
<0.001 
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Table 2: Categories of proteins affected by Cnot3 KO in β cells obtained from MS 
analysis of Cnot3βKO islets 
Category Protein symbol 
Glycolysis GCK (FC=1, P=0.4), G6PC2 (FC=1.6, P=0.13) 
Glucose sensing and 
Insulin secretion 
GLUT2 (FC=0.4, P=0.1), GLP1R (FC=0.58, P=0.0007), 
UCN3 (FC=0.4, P=0.02) 
Insulin granule feature VAMP2 (FC=0.6, P=0.01), SLC30A8 (FC=0.4, P=0.049), 
SYTL4 (FC=0.9, P=0.4), PC1 (FC=0.48, P=0.09), PC2 
(FC=0.58, P=0.007), CPE (FC=0.3, P=0.002) 
Immature/ β cell 
disallowed  
ACOT7 (FC=1.55, P=0.1), HK1 (FC=2, P=0.003), ALDOC 
(FC=3.1, P=0.02), LDHA (FC=1.89, P=0.04) 
Affected β cell markers are in bold     
              MS analysis is done by Dr. Yibo Wu     
2.3.7 Transcriptome- and proteome-wide changes in Cnot3βKO islets 
To understand how loss of Cnot3 affects global gene expression in β cells, I performed RNA-
seq of control and Cnot3βKO islets (three replicates; each replicate comprised islets pooled 
from two mice). Comparison of gene expression profiles between control and Cnot3βKO islets 
revealed 3,847 differentially expressed (DE) genes (adjusted P< 0.05), of which 2,234 genes 
were upregulated and 1,613 genes were down regulated (Figure 2.12a). To define the biological 
processes affected by Cnot3 depletion, I performed GO analysis of the DE genes using the 
DAVID gene annotation tool (Huang et al., 2008; Sherman et al., 2008) (Figure 2.12b). 
Consistent with the diabetic phenotype, GO analysis showed that genes upregulated 
after Cnot3 depletion are highly enriched for those involved in: “immune system process”, 
“lipid metabolic processes” and “oxidation/reduction processes”, while down regulated genes 
are highly enriched for those that are involved in regulation of insulin secretion and vesicle-
mediated transport.  
To gain more insight into the effect of Cnot3 depletion on the pattern of gene expression 
in β cells, I applied a stricter threshold by comparing the number of significantly upregulated 
to down regulated genes that were differentially expressed by more than 2-fold. In line with 
the molecular function of CNOT3 as a positive modulator of CCR4-NOT complex function in 
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mRNA decay, most of the differentially expressed genes by more than 2-fold were upregulated 
(Figure 2.12c). 
I next examined whether changes in transcriptome are reflected on proteome of 
Cnot3βKO islets. I compared RNA-seq to MS data from Cnot3βKO islets. There was a 
significant strong correlation between DE genes and proteins in Cnot3βKO islets (R2 = 0.64, 
P< 2.2e-16) suggesting that most changes in the transcriptome are mirrored in the proteome 
(Figure 2.12d). 
Steady-state mRNA abundance is mainly determined by rates of RNA transcription and 
decay. Measuring the mRNA decay rate usually involves performing a time series analysis of 
mRNA abundance following blockade of transcription by certain chemicals, for example Act. 
D, or by monitoring the abundance of labeled mRNA using high-throughput pulse-chase 
methods (Chen et al., 2008). These methods work well for cultured cells but cannot easily be 
used for measuring mRNA decay rate in tissue samples. Thus, I used transcriptomic data to 
infer mRNA stability in Cnot3βKO islets. While exonic read counts in RNA-seq data 
correspond to steady-state mRNA abundance, changes in abundance of intronic reads can be 
used to estimate changes in transcription rate. In this way I was able to infer global mRNA 
stability from RNA-seq data. I estimated the change in mRNA half-life as the difference of the 
logarithm of the FC in exonic reads and the logarithm of the FC in intronic reads (∆exon-
∆intron) (Gaidatzis et al., 2015). The fact that CNOT3 is involved in mRNA deadenylation and 
subsequently mRNA decay led me to consider a transcript to be a target of CNOT3 if that 
transcript was upregulated and stabilized as inferred from RNA-seq data. I found that 80% (254 
of 317 mRNAs) of stabilized mRNAs that show differential ∆exon-∆intron between 
Cnot3βKO and control islets were among the differentially upregulated mRNAs, suggesting 
that mRNA stabilization effectively contributed to upregulation of mRNAs in Cnot3βKO islets 
(Figure 2.12e). I compared upregulated stabilized genes in Cnot3βKO islets to published RNA-
seq data from db/db islets (Neelankal John et al., 2018) and found 73 upregulated stabilized 
genes to be upregulated in db/db islets suggesting that CNOT3 is involved in suppressing 
diabetes-related genes. 
Interestingly, transcriptome analysis revealed Aldolase B gene (Aldob) to be the most 
upregulated (almost 1000-fold) of the stabilized genes. Aldob is a glycolytic enzyme that is 
normally silenced in mature β cells (Dhawan et al., 2015; Ni et al., 2017). It was dramatically 
upregulated at both mRNA and protein levels (Figure 2.12f-h). In addition, the fructose/glucose 
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transporter, Slc5a10, and Wnt5b were among the most stabilized genes, and they were 
upregulated (Figure 2.12f). 
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Figure 2.12 Global gene expression changes in Cnot3βKO islets 
(a) 3,847 genes were differentially expressed in islets on CNOT3 depletion in β cells. The 
graph indicates the percentage distribution of DE genes (P< 0.05) in Cnot3βKO compared with 
control islets. (b) GO analysis of significantly upregulated (upper) and down regulated (lower) 
mRNAs in Cnot3βKO islets. Bar charts of GO terms (Biological Process) ranked by FDR (< 
0.05) are shown. (c) Volcano plot of DE genes indicating the percentage distribution of DE 
genes (P< 0.05) with a FC of at least 2, upregulated (red) and down regulated (blue). (d) 
Pearson correlation analysis between DE genes and proteins inferred from RNA-seq analysis 
and MS analysis of control and Cnot3βKO islets. (e) Venn diagram showing the overlap of 
significantly upregulated and stabilized genes in Cnot3βKO compared with control islets. (f) 
qPCR analysis of three top upregulated and stabilized mRNAs (Aldob, Slc5a10 and Wnt5b), 
normalized to the Gapdh mRNA level, in control and Cnot3βKO islets (n=3-6). (g), 
Immunoblot analysis of ALDOB in islet lysates from 8-week-old control and Cnot3βKO mice 
(n=3). (h) Band quantification of immunoblots of ALDOB (n=3). Data are presented as mean 
± S.E.M; * P < 0.05; ** P <0.01; *** P <0.001. 
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2.3.8 Derepression and stabilization of β cell disallowed genes in Cnot3βKO islets 
Based on the findings that CNOT3 affects β cell identity, it was intriguing to find out if CNOT3 
is important for the decay of β cell disallowed genes. Two founding studies identified 68 of 
these genes by microarray analysis (Pullen et al., 2010; Thorrez et al., 2011). More recently, a 
novel study identified a new list of β cell disallowed genes based on RNA-seq data of islets, β 
and α cells (Pullen et al., 2017). I performed gene set enrichment analysis (GSEA) of the most 
recent list of 61 β cell disallowed genes identified in Pullen et al., 2017 study which revealed 
the enrichment of these β cell disallowed genes in the current study transcriptome data set 
(Figure 2.13a, b).   
I inferred the mRNA stability of some of these disallowed genes together with Aldob, 
Slc5a10 and Wnt5b from transcriptome analysis (Figure 2.12e). Some genes were filtered out 
in the statistical analysis, due to low expression values, that hindered the assessment of their 
mRNA stability. I validated this stability analysis by treatment of control and Cnot3βKO islets 
with Act. D and determined their relative abundances after 4 and 8 hrs. Aldob, Wnt5b, Cat, 
Abtb2 and Fgf1 were significantly stabilized (Figure 2.13c). On the other hand, other 
upregulated mRNAs: Hk1, Rest and Yap1 were not stabilized (Figure 2.13c). This suggests that 
the stabilized genes are targets of CNOT3 dependent mRNA decay, whereas the unstabilized 
genes may be upregulated indirectly by Cnot3 depletion, rather than via their decay. I couldn’t 
assess the mRNA stability of Slc5a10, Slc16a1, Ldha and Pdgfra experimentally. This could 
be due to their very low expression levels. Yet, based on statistical evaluation of exon and 
intron counts, I found that among these genes, Slc5a10 (logFC= 4.76, FDR=1.7e-17) was 
stabilized in Cnot3βKO islets. 
To further understand the mechanism by which CNOT3 alters mRNA stability, I asked 
whether the affected genes interact with CNOT3. To answer this question, I carried out RIP 
assay using MIN6 cell line lysates with an antibody specific for CNOT3 and negative control 
immunoglobulin G (IgG). RNA from total extracts (Input), IgG and CNOT3-
immunoprecipitated samples were analyzed by qPCR. Among β cell disallowed genes analyzed, 
Slc16a1, Ldha, Cat, Abtb2, Fgf1, Igfbp4, Acot7 and Cxcl12 were significantly enriched in 
CNOT3-immunoprecipitated samples compared with IgG-immunoprecipitated samples 
(Figure 2.13d). These data suggest that the above genes interact with CNOT3. Interestingly, 
among the examined β cell disallowed genes is Yap1 which I found not interacting with 
CNOT3 (Figure 2.13d) and whose mRNA decay rate was not affected in Cnot3βKO mice 
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(Figure 2.13c). This observation implies that Yap1 upregulation after Cnot3 deletion is an 
indirect effect (possibly on transcription) rather than a result of reduced decay. Taken 
together, my data suggest that Cnot3 depletion resulted in decreased decay rates and increased 
protein synthesis of target transcripts. 
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Figure 2.13 Derepression of β cell disallowed genes and their stabilization in Cnot3βKO 
islets 
(a) GSEA of β cell disallowed gene list, identified in Pullen et al, 2017 study, in Cnot3βKO 
islets. (b) Heatmap of 30 disallowed genes showing mRNA expression obtained from RNA-
seq analysis of control and Cnot3βKO islets. (c) Decay curves of the indicated mRNAs. Total 
RNA was prepared from control and Cnot3βKO islets treated with Act. D (0, 4 or 8h). Relative 
mRNA levels were determined by qPCR and normalized to the Gapdh mRNA level. mRNA 
level without Act. D treatment (0h) was set to 100% (n=3). (d) RIP-qPCR in MIN6 cells using 
normal anti-mouse and anti-CNOT3 antibodies revealing the interaction of CNOT3 with 
selected mRNAs that adversely affect β cell function (n=3). Data are presented as mean ± 
S.E.M; * P < 0.05; ** P <0.01; *** P <0.001 
 
To exclude the possibility that the observed immature phenotype is merely caused by 
hyperglycemia, I performed experiments on euglycemic 4-week-old Cnot3βKO mice. I 
observed significant down regulation of Mafa, Ins1 and Ins2, and significant upregulation of 
Aldob, Slc5a10, Wnt5b, Hk1 and Tnfrsf11b, suggesting that this molecular defect is due to a 
direct effect of loss of Cnot3, rather than to hyperglycemia (Figure 2.14). 
   
d 
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Figure 2.14 Molecular deregulation by CNOT3 loss is observed in 4-week-old mice 
qPCR analysis of: (a) β cell specific markers, (b) Immaturity markers and disallowed genes, 
and (c) top upregulated and stabilized genes as inferred from transcriptome data. 
Data are presented as mean ± S.E.M; * P < 0.05; ** P <0.01; *** P <0.001 
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2.3.9 Roquin recruits CCR4-NOT complex to the 3’UTR of Slc16a1 mRNA and other 
plausible target mRNAs for the control of their stability  
While direct recruitment of the CCR4–NOT complex to target mRNAs destined for 
deadenylation and decay is mediated by several RBPs that interact with ARE in 3’UTRs. I tried 
to identify RBPs that mediate the CCR4-NOT complex interaction with Slc16a1, Ldha, Wnt5b 
and Abtb2 in β cells. To identify proteins that recruit CCR4-NOT complex, cellular extracts of 
MIN6 cells were incubated with FLAG-tagged fragments of Slc16a1, Ldha, Wnt5b and Abtb2 
mRNA 3’UTR for pull down analysis as previously described (Takahashi et al., 2015).  The 
Slc16a1 3’UTR was divided into six constructs (Slc16a1-1, Slc16a1-2, Slc16a1-3, Slc16a1-4, 
Slc16a1-5 and Slc16a1-6), Wnt5b 3’UTR  into two constructs (Wnt5b-1 and Wnt5b-2), and 
Abtb2 3’UTR  into two constructs (Abtbt-1 and Abtbt-2) because the technique used for fusing 
a FLAG tag has a size limitation (Adachi and Natsume, 2015). As shown in Fig. 2.15a, 
Slc16a1-4 interacted with cytoplasmic Roquin whereas the other fragments didn’t interact. 
Also, Ldha, Wnt5b and Abtb2 3’UTR interacted with Roquin (Fig. 2.15b).  
To determine whether CNOT3 interacts with Roquin in an RNA-independent manner, 
cellular extracts of control and FLAG-tagged CNOT3 expressing MIN6 cells were treated with 
RNase A, and the immunoprecipitates were analyzed and compared by immunoblotting. 
Roquin showed a direct interaction with CNOT3 whereas HuR, another RBP known to interact 
with ARE, didn’t interact with CNOT3 (Fig. 2.15c).  
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Figure 2.15 Roquin recruits CCR4-NOT complex to the 3’UTR of Slc16a1, Ldha, Wnt5b 
and Abtb2 mRNA 
(a-b) MIN6 cells lysates were incubated with FLAG-tagged (a) Slc16a1, (b) Ldha, Wnt5b and 
Abtb2 3’UTR fragments and then immunoprecipitated with anti-FLAG antibody. Immune 
complexes were analyzed by immunoblot analysis with anti-Roquin and anti-CNOT3 
antibodies. (c) Lysates prepared from MIN6 cells which were transfected with FLAG-tagged 
CNOT3 and subjected to immunoprecipitation with anti-FLAG antibody. CNOT3 (FLAG) is 
shown in red to indicate a precipitated molecule. Lysates and IP were analyzed by immunoblot 
analysis. 
2.4 Discussion   
Loss of β cell identity and dedifferentiation are increasingly recognized as contributors to 
impaired β cell function in T2D (Talchai et al., 2012). However, the molecular underpinnings 
of these events are still unclear. The principal aim of the present study was to elucidate the role 
of the CCR4-NOT complex, a key regulator of post-transcriptional gene expression, in β cells. 
I first found that CNOT3, along with CNOT1 and CNOT2, was decreased in diabetic mouse 
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islets, implying that disruption of the CCR4-NOT complex could be a pathogenic factor in 
diabetes. To understand the role of the CCR4-NOT complex in β cells I generated Cnot3βKO 
mice in which Cnot3 is specifically knocked out in β cells by Ins1-Cre at the onset of insulin 
gene expression. In this way, I demonstrated that CNOT3 is crucial for β cell maturation and β 
cell identity. β cell maturation occurs postnatally in the first few weeks of life when β cells 
acquire GSIS feature (Blum et al., 2012). This process involves increased expression of β cell-
specific genes, such as Mafa, Gck and Ucn3, and the loss of expression of other genes that 
would interfere with normal β cell function – β cell disallowed genes (Blum et al., 2012; Pullen 
et al., 2010; Rutter et al., 2015). Molecular mechanisms governing the process of β cell 
maturation and acquisition of functional and molecular identities are not fully understood.  
The process of GSIS in mature β cells is regulated primarily by the levels of 
extracellular glucose. Unlike immature β cells, which secrete insulin under low glucose 
conditions, mature β cells secrete insulin in response to rises in blood glucose, thus maintaining 
normal glucose homeostasis without causing hypoglycemia (Dhawan et al., 2015). Mature 
rodent β cells take up glucose via GLUT2 localized to the cell membrane. Upon its uptake, 
glucose is metabolized by Gck followed by glycolytic breakdown to pyruvate which enters the 
TCA cycle in the mitochondria to generate ATP. The increased ATP/ADP ratio causes the 
closure of ATP-sensitive potassium channels, leading to depolarization of the plasma 
membrane, which opens voltage-dependent calcium channels allowing the influx of calcium. 
Increased intracellular calcium causes fusion of insulin granules to the plasma membrane for 
insulin exocytosis (Rorsman and Renström, 2003; Rutter et al., 2015). Here, I show that 
CNOT3 is essential for both the maintenance of normal β cell mass, as well as the functional, 
differentiated state of these cells. Notably, GSIS is impaired in Cnot3βKO mice, suggesting 
impaired glucose metabolism. Impaired glucose metabolism could be due to decreased GLUT2 
expression and defects in maturity. Expression of glycolytic genes, such as Hk1, Hk2 and Ldha, 
is sharply down regulated during β cell maturation (Liu and Hebrok, 2017). I observed 
increased expression of these glycolytic genes alongside with other markers of immature β cell: 
Slc16a1, Rest and Pdgfra (Figure 2.11). Ectopic expression of Hk1, Slc16a1 and Ldha has been 
reported to impair glucose metabolism and GSIS (Alcazar et al., 2000; Becker et al., 1994; 
Pullen et al., 2012; Zhao and Rutter, 1998). Moreover, decreased expression of Pdgfra during 
maturation is responsible for decreased proliferation in the mature β cell necessary for normal 
GSIS (Chen et al., 2011b). 
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Nearly all fully processed eukaryotic mRNAs possess poly (A) tails at their 3’ ends. 
Poly(A) tail length is suggested to influence mRNA stability (Eckmann et al., 2011; Norbury, 
2013). Deadenylation of these 3’ tails is the rate-limiting step in mRNA decay and translational 
silencing. Suppression of any of the CCR4-NOT complex subunits in cell lines and tissues 
results in stabilization of its target genes due to elongation of the poly(A) tail (Ito et al., 2011b; 
Suzuki et al., 2019). In my study, the β cell dysfunction and lack of β cell maturation in 
Cnot3βKO mice, which cannot deadenylate mRNAs in β cells (Figure 2.2 c, d), is coincident 
with the upregulation and stabilization of various genes. Among these genes are Aldob, Slc5a10 
and Wnt5b (Figure 2.12 f), whose upregulation is shown to be correlated with diabetes (Gerst 
et al., 2018; Haythorne et al., 2019; Lee et al., 2008; Solimena et al., 2018). ALDOB is a 
glycolytic enzyme that is positively correlated with glycated hemoglobin in T2D patients and 
negatively correlated with insulin secretion (Gerst et al., 2018). Increases of the 
glucose/fructose transporter, SLC5A10, are associated with inhibition of mitochondrial 
metabolism and decreased insulin secretion (Haythorne et al., 2019). Wnt5b, a member of the 
Wnt gene family, has been identified as a candidate gene for susceptibility to T2D (Kanazawa 
et al., 2004), but it has not been determined whether this occurs through a direct effect on the 
islets or in peripheral tissues. Moreover, it is still not known whether Wnt signaling in islets 
plays a role in pathogenesis of diabetes or whether it is activated as a compensatory mechanism 
during the progression of the disease. Interestingly, prolonged activation of Wnt signaling is 
shown to affect the differentiated state of β cells (Heiser et al., 2006; Lee et al., 2008). In 
addition, there is an inverse correlation between Wnt signaling activation and insulin gene 
expression, which suggests a deleterious effect of Wnt signaling activation on β cell function 
(Lee et al., 2008). These results are in agreement with previous findings that the CCR4-NOT 
complex is involved in regulation of energy metabolism genes (Li et al., 2017; Morita et al., 
2011; Takahashi et al., 2015). Moreover, I demonstrated that disallowed genes are 
preferentially upregulated by Cnot3 KO (Figure 2.13 a, b). Therefore, it is conceivable that 
CNOT3 is involved in silencing of these genes.  
β cell disallowed genes are selectively silenced in β cells. Their repression is part of β 
cell identity acquired during postnatal maturation and ensures normal GSIS (Pullen and Rutter, 
2013), but their roles in affecting normal β cell function are not fully elucidated. However, 
repression of Slc16a1 and Ldha, two founder members of β cell disallowed genes, were 
proposed to prevent lactate and pyruvate, produced from muscle during exercise, from 
inappropriately stimulating insulin release (Thorrez et al., 2011). The molecular mechanisms 
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involved in repressing these genes are largely unknown. Thus, it is currently unclear whether 
there is a general silencing mechanism for all disallowed genes, or several molecular 
mechanisms are involved. Transcriptional epigenetic mechanisms such as DNA methylation 
are shown to be involved in repressing several disallowed genes (Pdgfra, Acot7, Igfbp4 and 
Fgf1) (Ni et al., 2017). Of note, DNA methylation is generally essential for β cell maturation 
and contributes to repression of immature β cell genes including Aldob, Hk1, Hk2 and Ldha 
(Dhawan et al., 2015). Histone methylation may also be involved. The trimethylation of histone 
H3 on lysine 27 (H3K27me3), was found in the Slc16a1 promoter (van Arensbergen et al., 
2010) and several other disallowed genes (Cxcl12, Acot7, Nfib, Mgst1, Maf) (Pullen and Rutter, 
2013). Several studies have revealed that miRNAs down regulate Slc16a1, Acot7, Fcgrt, Igfbp4, 
Maf, Oat and Pdgfra (Martinez-Sanchez et al., 2015; Martinez-Sanchez et al., 2016; Pullen et 
al., 2011). One possible mechanism of the CCR4–NOT complex target recognition is through 
miRNAs (Chekulaeva et al., 2011; Fabian et al., 2011). It is conceivable that the CCR4–NOT 
complex is involved in post-transcriptional regulation of relevant miRNA targets in β cells.  
The current study provides evidence that deadenylation by the CCR4–NOT complex is 
involved in repressing Aldob, Slc5a10, Wnt5b and several disallowed genes through both direct 
and indirect mechanisms. I considered that upregulated stabilized genes were more likely to be 
directly regulated by CNOT3-dependent deadenylation by the CCR4-NOT complex. 
Investigations of mRNA stability have shown that Cnot3 KO results in increased stability of 
Aldob, Slc5a10, Wnt5b, Cat, Abtb2 and Fgf1 (Figure 2.13 c). Moreover, the finding that 
CNOT3 directly interacts with Wnt5b, Cat, Abtb2 and Fgf1 (Figure 2.13 d) supports direct 
repression of these genes by CNOT3. However, I could not determine the mRNA stability of 
some of the investigated disallowed genes in Act. D chase experiments. Other methods for 
assessing mRNA stability, such as monitoring the abundance of labeled mRNA using high-
throughput pulse-chase methods could not be applied to islets owing to the low quantity of 
RNA that could be extracted from them. Also, we were only able to assess bulk poly(A) tail 
length elongation in Cnot3βKO islets (Figure 2.2c, d). However, owing to the very low 
expression levels of most target genes, I couldn’t assess their poly(A) tail lengths using 
currently available techniques. For the same reason, I was unable to detect direct binding of 
CNOT3 to its plausible targets, Aldob and Slc5a10, using a conventional RIP assay.  
On the other hand, indirect effects of CNOT3 suppression on gene expression likely 
involve changes in expression of key transcription factors. Of note, it was recently reported 
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that MafA (Nishimura et al., 2015), Pax6 (Swisa et al., 2017), Rfx6 (Piccand et al., 2014) and 
Nkx2.2 (Gutierrez et al., 2017) act as repressors of several disallowed genes and changes in 
any of these factors may be involved in upregulation of  disallowed genes. Among these 
repressors only MafA was significantly decreased in Cnot3βKO islets (Figure 2.10 a, e). 
Therefore, I cannot exclude the possibility that repression of MafA in Cnot3βKO islets also 
contributes to increased expression of disallowed genes. Moreover, down regulation of MafA 
could explain upregulation of endocrine progenitor cell markers observed in Cnot3βKO islets 
(Figure 2.9 a-c). Upregulation of these progenitor markers, as a result of MafA down regulation, 
hallmarks dedifferentiation state in β cells and upregulates β cell disallowed genes (Nishimura 
et al., 2015). Indeed, Slc16a1 was upregulated but not stabilized. Thus, I propose that Slc16a1 
is upregulated indirectly by CNOT3 through MafA repression. This comes in agreement with 
its upregulation observed in dedifferentiated β cells of Mafa KO mice (Nishimura et al., 
2015). The Mafa suppression mechanism was not determined in this study. Taken together, my 
data and that of others’ data suggest that repression of disallowed genes is achieved by multiple 
mechanisms. 
I showed here that CNOT3 is required for normal β cell maturation, sustaining 
expression of β cell-specific genes and repressing that of disallowed genes. These findings, 
together with the observed decreased expression of CNOT3 in db/db diabetic mouse model 
(Burke et al., 2017), raise the possibility that disruption of the CCR4–NOT complex could be 
behind the loss of β cell identity in diabetes, possibly through loss of repression of immature β 
cell and disallowed genes. I found that glucotoxicity and lipotoxicity did not change CNOT3 
levels; thus, I propose that other factors in diabetes may be involved in perturbing its protein 
levels. Interestingly, proteomic analysis of human islets revealed significant reduction of 
CNOT3 during high glucose treatment (Schrimpe-Rutledge et al., 2012). Further studies are 
required to identify the molecular mechanisms that control CNOT3 levels during diabetes.  
In the mammalian CCR4-NOT complex, CNOT3 does not have well-defined RNA 
binding motifs but rather forms a platform for interaction with RBPs via direct protein-protein 
interactions. The recognition of target mRNAs by the CCR4-NOT complex is, hence, likely 
mediated through RBPs. One of the well characterized cis-acting elements for regulation of 
mRNA stability is AU-rich elements (ARE) found in the 3′UTRs (Bhandari et al., 2014; Braun 
et al., 2011; Leppek et al., 2013; Sgromo et al., 2017; Van Etten et al., 2012) . Previous 
research by our group and others elucidated the recruitment of the CCR4-NOT complex to 
target 3’UTRs by TTP protein family (Fabian et al., 2013; Takahashi et al., 2015). I was unable 
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to detect this family of proteins in β cells (data not shown). On the other hand, I identified 
Roquin, an mRNA binding protein, that interacts specifically with a stem loop constitutive 
decay element in 3’UTR (Leppek et al., 2013) and recruits CNOT3 to some of investigated 
mRNAs: Slc16a1, Ldha, Wnt5b and Abtb2 3’UTRs. Interestingly, Roquin was found to interact 
directly with Slc16a1 in HEK293 cells and MEFs by Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) technique (Essig et al., 2018; 
Murakawa et al., 2015). Future investigations are needed to identify sequences in the 
investigated target mRNAs to which Roquin interacts and examine the mRNA stability of these 
target mRNAs in the absence of Roquin. 
In conclusion, this study identifies CNOT3 as a key post-transcriptional regulator of 
β cell identity and function, and raises the possibility that changes in CNOT3 expression or 
activity contribute to β cell failure in diabetes. 
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 Chapter 3: Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT 
complex in mRNA regulation and cell viability 
3.1 Introduction 
Regulation of mRNA decay in the cytoplasm is important for proper gene expression, and its 
dysregulation causes various disorders. Shortening of mRNA poly(A) tails by deadenylation is 
the initial, rate-limiting step in the exonucleolytic mRNA decay pathway, which is also relevant 
to translational suppression (Garneau et al., 2007; Parker, 2012). mRNA deadenylation occurs 
via two distinct steps. First, PAN2-PAN3 trims long poly(A) tails to ~110 nucleotides (nt) and 
subsequently, the CCR4-NOT complex completes deadenylation (Wahle and Winkler, 2013; 
Yamashita et al., 2005).  
The CCR4-NOT complex is critical to a variety of physiological functions in mammals, 
including energy metabolism, B-cell development, heart function, and liver maturation, via 
mRNA deadenylation and subsequent degradation (Inoue et al., 2015; Morita et al., 2011; 
Suzuki et al., 2019; Yamaguchi et al., 2018). Mouse embryonic development also requires 
CCR4-NOT complex activity, as mice lacking the Cnot1 or Cnot3 genes (Cnot1-KO or Cnot3-
KO mice, respectively) show embryonic lethality (Morita et al., 2011; Yamaguchi et al., 2018). 
Furthermore, suppression of CCR4-NOT activity leads to cell death via apoptosis or 
necroptosis, indicating the importance of the CCR4-NOT complex in cell viability (Inoue et 
al., 2015; Ito et al., 2011b; Mittal et al., 2011; Suzuki et al., 2019; Suzuki et al., 2015; 
Yamaguchi et al., 2018). 
Several studies have described different roles of the catalytic subunits in deadenylase 
activity and biological processes, but their individual biological roles are not fully understood. 
In yeast, current evidence suggests that Ccr4, the ortholog of CNOT6/6L, is the dominant 
deadenylase subunit of CCR4-NOT (Tucker et al., 2001). On the other hand, DEDD family 
proteins: Ccf1 (Caf1 ortholog) and CNOT7/8 possess the main activity in C. elegans and 
mammals respectively (Nousch et al., 2013; Piao et al., 2010). Suppression of Cnot6l or both 
Cnot6/6l in human cancer cell lines leads to proliferation arrest and cell death in a deadenylase 
activity-dependent manner, indicating the importance of CNOT6/6L in mammals (Mittal et al., 
2011; Morita et al., 2007). In the same study, it was shown that CNOT6/6L and CNOT7/8 
regulate distinct groups of genes (Mittal et al., 2011). Therefore, CNOT6/6L and CNOT7/8 
serve different functions, depending on cell types, biological processes, and target genes. 
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Importantly, recent studies show that CNOT6/6L and CNOT7/8 display distinct biochemical 
activities in deadenylation. These differences possibly explain why two different types of 
ribonuclease in a single complex (Webster et al., 2018; Yi et al., 2018). The two paralogs, 
CNOT6/6L and CNOT7/8, in mammals have been considered basically redundant. Cnot6l-KO 
or Cnot7-KO mice are viable and normally grow to adulthood, supporting their functional 
redundancy, at least in mouse embryonic development and in embryo-to-adult viability 
(Berthet et al., 2004; Morita et al., 2019; Nakamura et al., 2004). On the other hand, while 
CNOT7 and CNOT8 have overlapping roles in some cases, as in growth of human breast cancer 
cell line, MCF7 cells (Aslam et al., 2009), they also have unique roles in other contexts. For 
instance, male Cnot7-KO mice are sterile due to defects in spermatogenesis, suggesting that 
CNOT8 cannot compensate for loss of CNOT7 in this process (Berthet et al., 2004; Nakamura 
et al., 2004). To better understand the different biological roles of the four catalytic subunits, 
further analyses are necessary to clarify their distinctive functions in various biological 
contexts. 
In this chapter, I addressed the contribution of CNOT7/8 and CNOT6/6L to CCR4-
NOT complex deadenylase activity and viability of primary MEFs. I used primary MEFs 
prepared from mice lacking CCR4-NOT complex subunits. Since Cnot1-KO, Cnot3-KO, and 
Cnot8-KO mice are embryonically lethal (Morita et al., 2011; Neely et al., 2010; Yamaguchi 
et al., 2018), I prepared MEFs from mice possessing conditional alleles in which loxP 
sequences were inserted, and I deleted the corresponding targets using Cre-mediated somatic 
recombination. Given that primary MEFs lacking CCR4-NOT complex-dependent 
deadenylation undergo cell death (Suzuki et al., 2015), roles of the catalytic subunits in cell 
viability were investigated.  
3.2 Materials and Methods 
3.2.1 Cell culture 
MEFs were prepared as described previously (Suzuki et al., 2015). A timed mating was set 
between male and female mice. On the following day, plug was checked. The day when the 
plug is detected is considered E0.5. MEFs were prepared from E14.5 embryos extracted from 
pregnant mice.  The pregnant mice were anaesthetized using isoflurane and euthanized by 
cervical dislocation, then the embryos were retrieved. The head and internal organs were 
carefully removed and discarded. Part of the head was used for genotyping. Then, embryos 
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were minced by scissors and dissociated in 0.25% trypsin (Gibco) at 37° C for 5 min. Trypsin 
was diluted by adding low glucose Dulbecco's modified Eagle's medium (Wako) supplemented 
with 10% FBS and 1% penicillin-streptomycin. Then, the cells were washed once in medium. 
Afterwards, the cells were plated on tissue culture flask in low glucose Dulbecco's modified 
Eagle's medium containing 10% FBS and 1% Penicillin-Streptomycin, cultured at 37° C until 
confluency.  
I used Cnot1-flox MEFs infected with mock retrovirus and Cnot7+/+; Cnot8-flox MEFs 
(littermates of Cnot7-KO; Cnot8-flox MEFs) infected with mock retrovirus, as controls for 
Cnot1-KO and Cnot7/8-dKO MEFs, respectively. I used wild-type (WT) MEFs with the same 
passage number as controls for Cnot6/6l-dKO MEFs. 
3.2.2 Virus infection 
MEFs infection with retrovirus (mock or Cre) was performed as described previously (Suzuki 
et al., 2002). Retroviruses (mock and Cre) were produced by transfecting Plat-E packaging 
cells with 2 μg empty pMX-puro plasmid or 2 μg pMX-puro-Cre plasmid (Suzuki et al., 2015) 
using TransIT-LT1 transfection reagent (Takara). Two days after transfection, cell culture 
supernatants containing the retroviruses were filtered and polybrene (0.5 μg/mL) was added. 
The resultant viral solutions were used for infection of MEFs that were 40% confluent. Two 
days after viral infection, cells were diluted following trypsinization and cultured in the 
presence of puromycin (1 µg/mL) for an additional 2 days to select infected cell populations.   
In the series of rescue experiments: FLAG-tagged CNOT7-WT and CNOT7-mutants: 
catalytically negative (CNOT7-CN) and dominant negative (CNOT7-DN) constructs were 
inserted into pMX vectors and used for retrovirus production for infecting MEFs as shown 
above for mock and Cre retrovirus infection. Adenovirus infection [control (GFP) and Cre] 
was performed 2 days after retrovirus infection at MOI 7.5. Two days later, adenovirus-infected 
MEFs were used for immunoprecipitation. For cell death analysis, MEFs were cultured in the 
presence of puromycin (1 µg/mL) for additional 2 days. 
3.2.3 Immunoprecipitation and immunoblotting 
MEFs were lysed with TNE lysis buffer (1% NP-40, 50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 
1 mM EDTA, 1 mM phenylmethylsulfonylfluoride, and 10 mM NaF). I used 5% of each lysate 
for immunoblot analysis (Lysates). The remainder of each lysate was used for 
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immunoprecipitation and were incubated with anti-CNOT3 antibody for 1 hr at 4° C in an 
upside-down tumbling manner followed by incubation with Protein G Sepharose (GE 
Healthcare) for 2 hrs at 4° C in an upside-down tumbling manner. Immune complexes were 
subjected to immunoblot analysis following SDS-PAGE standard protocols described in 
section 2.2.6. Primary and secondary antibodies used are listed in Table 4 and Table 5 
respectively. 
3.2.4 Measurement of cell survival rate 
Cell viability was measured by the ability of cells to exclude propidium iodide (PI). Cell culture 
supernatants containing floating dead cells were collected and attached cells were treated with 
0.1% Trypsin, collected by centrifugation, washed once with phosphate-buffered saline (PBS), 
and resuspended in PBS containing 5 μg/mL of PI (Sigma). Levels of PI incorporation were 
quantified using FACS Calibur (Becton Dickinson). 
3.2.5 RNA extraction 
Total RNA was extracted from MEFs as described in section 2.2.13. 
3.2.6 mRNA stability measurement and qPCR 
To measure mRNA stability, 4 days after viral infection including the two days of puromycin 
selection, cells were treated with Act. D (2.5 μg/mL); and total RNA was extracted at 0, 4 and 
8 hrs and used for RNA-seq and qPCR. Total RNA (1 μg) was used for reverse transcription 
with oligo(dT)12-18primer (Invitrogen) using the SuperScript III First-Strand Synthesis 
System (Invitrogen). qPCR reactions were carried out using TB Green Premix Ex Taq (Takara) 
and the ViiA 7 Real-Time PCR System (Applied Biosystems). Gapdh mRNA levels were used 
for normalization. Relative mRNA expression was determined by the ∆∆CT method. Primers 
for qPCR reactions are listed in Table 8. 
3.2.7 Bulk poly(A) tail assay 
Total RNA (10 µg) was used for bulk poly(A) tail analysis following the same protocol 
described in section 2.2.14. 
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3.2.8 RNA sequencing 
RNA-seq was performed by the Next Generation Sequencing section at OIST Graduate 
University for two biological replicates per condition; following the same protocol described 
in section 2.2.15. 
3.2.9 RNA sequencing data analysis 
Paired-end RNA-seq data were mapped to the Mus musculus reference strain mm10 UCSC 
using Strand NGS software (Strand Genomics). Transcript abundance for each replicate was 
measured in Fragments Per Kilobase Mapped (FPKM). Genes with FPKM < 0.1 were filtered 
out, and only “protein-coding genes” were considered. For comparison, I used gene expression 
values defined as Gene FPKMs normalized with Gapdh FPKM. Fold changes in gene 
expression values (KO against control MEFs) were determined. Half-lives were calculated 
based on the decay rate of each transcript after suppression of transcription. Total RNA was 
prepared at 0, 4, and 8 h after Act. D treatment, and subjected to RNA-seq. To calculate the 
mRNA degradation rate constant ( 𝑘𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛), gene expression values were plotted on a 
semilogarithmic scale as a function of time (t). The line that best fit the data was identified 
using linear regression, then 𝑘𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛was obtained from the slope. The t1/2 was calculated 
by substitution in the equation: 
𝑡1/2 = ln(2) /𝑘𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 
mRNAs having half-lives less than 0 h or more than 50 h were excluded as unreliable. 
Cnot1-flox or Cnot8-flox MEFs infected with mock virus were used as controls for Cnot1-KO 
and Cnot7/8-dKO MEFs, respectively. WT MEFs were used as controls for Cnot6/6l-dKO 
MEFs. mRNAs having more than 2-fold longer half-lives compared to controls were 
considered stabilized genes. GO enrichment analysis was performed with DAVID 
Bioinformatics Resources 6.8 (https://david.ncifcrf.gov). 
3.2.10 Statistical analysis 
Differences between groups were examined for statistical significance using Student’s t-test 
(two-tailed distribution with two-sample equal variance). P value of <0.05 was considered 
statistically significant.  
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3.3 Results 
3.3.1 Simultaneous suppression of Cnot7 and Cnot8 causes marked cell death in MEFs 
Based on embryonic phenotypes of mice lacking each catalytic subunit in the CCR4-NOT 
complex, I prepared MEFs from mice with Cnot8-flox alleles (Cnot8-flox MEFs) and 
subsequently deleted the Cnot8 gene with Cre-mediated recombination to generate Cnot8-KO 
MEFs. I employed recombinant retrovirus to introduce Cre in MEFs. Cnot6-KO, Cnot6l-KO, 
Cnot7-KO (32), and Cnot6/6l-dKO MEFs were prepared from the corresponding KO mouse 
embryos. I also prepared Cnot7-KO/Cnot8-flox MEFs by crossing Cnot7-Het/Cnot8-flox pairs. 
Using Cre-mediated recombination, I generated Cnot7/8-dKO MEFs. For controls, mock-
infected MEFs were used. MEFs were also prepared from mice with Cnot1-flox alleles 
followed by Cre-mediated deletion of the Cnot1 gene (Cnot1-KO MEFs). Immunoblot analysis 
confirmed that expression of CNOT1 protein was substantially decreased (Figure 3.1a, b). 
CNOT1 protein was still detected after Cnot1 gene deletion. Our group previously observed a 
similar result in Cnot3-KO MEFs (Suzuki et al., 2015). I speculate that cells which had 
comparably high levels of CNOT1 protein before Cre-mediated gene deletion survived until 
the time of our analysis, while cells with reduced CNOT1 levels died. It is also possible that 
some cells escaped gene deletion due to insufficient Cre expression, because random 
integration of the Cre gene into the host genome leads to heterogeneous cell populations that 
vary in Cre expression. Expression of other CCR4-NOT complex subunits also decreased in 
Cnot1-KO MEFs, resulting in decreased expression of the whole complex, as shown by 
immunoprecipitation using anti-CNOT3 antibody (Figure 3.1a, b). Furthermore, the 
appearance of floating cells and a significant increase in the number of PI-incorporated cells 
indicated that Cnot1-KO MEFs underwent cell death (Figure 3c, d). Thereafter, I used Cnot1-
KO MEFs as a model of loss of viability due to loss of CCR4-NOT complex function, because 
they largely lack the CCR4-NOT complex.                        
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Figure 3.1 Cnot1-KO MEFs undergo cell death 
(a) Lysates were prepared from Cnot1-flox MEFs that were infected with mock or Cre-
expressing retrovirus and subjected to immunoprecipitation with anti-CNOT3 antibody. 
CNOT3 are shown in red to indicate a precipitated molecule. Lysates and immunoprecipitates 
(IP) were analyzed by immunoblot with the indicated antibodies. (b) Quantification of the 
immunoblot data in Figure 3.1a. Relative band intensities normalized to those of IP or lysates 
in control MEFs are shown (n=3). Data are presented as mean ± S.E.M. (c) Morphology of 
Cnot1-flox MEFs infected with mock (Control) or Cre-expressing retrovirus (Cnot1-KO). 
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Figure 3.1 (continued). Photographs are at the same magnification and represent one of three 
independent experiments. Dead cells that were about to lose adhesion were observed in Cnot1-
KO MEFs. (d) Cell death was assessed by propidium iodide uptake using flow cytometry (n=3). 
Data are presented as mean ± S.E.M. *P<0.05, **P<0.01, ***P< 0.001. 
Then, I examined viability of Cnot7/8-dKO and Cnot6/6l-dKO MEFs. Cnot7/8-dKO 
MEFs underwent cell death, while such outcomes were not observed in Cnot7-KO, Cnot8-KO, 
and mock-infected MEFs (Figure 3.2a, b). There was no significant difference in PI-
incorporated cells among Cnot6-KO, Cnot6l-KO, Cnot6/6l-dKO, and WT MEFs (Figure 3.2a, 
b). Therefore, CNOT6/6L are dispensable for MEF viability. In contrast, CNOT7 and CNOT8 
have redundant functions in maintaining MEF viability.  
 
 
Figure 3.2 Suppression of CNOT7/8, but not CNOT6/6L, affects viability of MEFs 
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Figure 3.2 (continued). (a) Morphology of MEFs with the indicated genotypes. Mock and Cre 
represent cells infected with retrovirus. (b) Cell death was assessed as in Figure 3.1d (n=3). 
Data are presented as mean ± S.E.M. ***P< 0.001.  
3.3.2 Cnot7/8 suppression results in loss of catalytic subunits from the CCR4-NOT 
complex 
Decreased levels of intact CCR4-NOT complex result in decreased MEF viability ((Suzuki et 
al., 2015), and Figure 3.1). I performed co-immunoprecipitation experiments to examine the 
effects of CNOT6/6L or CNOT7/8 suppression on complex formation. CNOT8 protein was 
still detected after Cnot8 gene deletion (Figure 3.3a), probably for the same reasons described 
in the case of Cnot1-KO MEFs (Figure 3.1a, see above). Importantly, immunoprecipitation of 
lysates from Cnot7/8-dKO MEFs with anti-CNOT3 antibody showed that levels of co-
immunoprecipitated CNOT6 and CNOT6L decreased substantially compared to control MEFs 
(Figure 3.3a), indicating that few catalytic subunits were associated with core subunits 
(CNOT1-3) of the CCR4-NOT complex in Cnot7/8-dKO MEFs. This is consistent with a study 
demonstrating CNOT7/8 bridge interaction between CNOT6/6L and CNOT1 (Clark et al., 
2004). I found that CNOT1, CNOT2, CNOT3, CNOT7, CNOT8, CNOT9, and CNOT10 
existed at similar levels in anti-CNOT3 immunoprecipitates among WT, Cnot6-KO, Cnot6l-
KO and Cnot6/6l-dKO MEFs (Figure 3.3b). These data suggest that loss of CNOT6/6L does 
not affect association of other CCR4-NOT complex subunits. 
 
Chapter 3 66 
 
 
 
 
Figure 3.3 CNOT6/6L are not part of CCR4-NOT complex in Cnot7/8-dKO MEFs 
(a) Lysates were prepared from Cnot8-flox MEFs with the indicated genotypes, which were 
infected with mock or Cre-expressing retrovirus and subjected to immunoprecipitation with 
anti-CNOT3 antibody. CNOT3 is shown in red to indicate a precipitated molecule. Lysates and 
IP were analyzed by immunoblot with the indicated antibodies. WT: wild-type, KO: knockout. 
(b) Lysates were prepared from MEFs with the indicated genotypes and subjected to 
immunoprecipitation with anti-CNOT3 antibody. Lysates and IP were analyzed by 
immunoblot. Data are presented as mean ± S.E.M. *P<0.05, **P<0.01, ***P< 0.001. 
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3.3.3 CNOT7 catalytic activity is essential to maintain MEF viability 
Rates of cell death were not increased in MEFs lacking CNOT6/6L relative to control cells, 
indicating that CNOT7/8 are sufficient for MEF viability (Figure 3.2a, b). To examine whether 
CNOT7/8 catalytic activity is critically involved in MEF viability, I introduced either FLAG 
epitope-tagged CNOT7-WT or CNOT7 mutants into Cnot7/8-dKO MEFs, using a recombinant 
retrovirus. CNOT7 mutants used included a catalytically negative mutant (CN; D40A/E42A), 
and a dominant negative mutant (DN; D40A/E42A/C67E/L71E), which lacked both catalytic 
activity and the capacity to bind CNOT6/6L (Mishima and Tomari, 2016). I first characterized 
CNOT7 mutants by overexpressing them in WT-MEFs. Results of immunoprecipitation with 
anti-FLAG antibody confirmed that CNOT7-WT and CNOT7-CN, but not CNOT7-DN, 
interacted with CNOT6/6L, whereas CNOT1 and CNOT3 were co-precipitated with all 
CNOT7 constructs (Figure 3.4a). I found that both CNOT7-CN and CNOT7-DN induced death 
in WT-MEFs (Figure 3.4b), suggesting that these mutants have a dominant negative effect on 
MEF viability. 
 
Figure 3.4 Characterization of CNOT7 mutants 
(a) Lysates prepared from WT MEFs which were infected with the indicated retrovirus and 
subjected to immunoprecipitation with anti-FLAG antibody. CNOT7 (FLAG) is shown in red 
to indicate a precipitated molecule. Lysates and IP were analyzed by immunoblot. WT: CNOT7 
wild-type, CN: CNOT7 lacking catalytic activity, DN: CNOT7 dominant negative mutant 
which lacks catalytic activity and an ability to bind to CNOT6/6L.  (b) Cell death was assessed 
as in Figure 3.1d (n=3). Cell death assay for this experiment was done by Dr. Toru Suzuki. 
Data are presented as mean ± S.E.M. ***P< 0.001. 
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In the series of the coming rescue experiments, I used a recombinant adenovirus 
expressing Cre to delete the Cnot8 gene. When CNOT7-WT was reintroduced into Cnot7/8-
dKO MEFs, cell viability was comparable to that of control (GFP) virus-infected MEFs (Figure 
3.5a, b). Expression of either CNOT7-CN or CNOT7-DN failed to recover viability, but further 
induced cell death (Figure 3.5a, b). This effect was likely caused by a dominant negative effect 
of CNOT7-CN and CNOT7-DN. Immunoblot analyses revealed the successful expression of 
FLAG-CNOT7-WT and mutants in Cnot7/8-dKO MEFs (Figure 3.5c, d). I found that the 
amount of CNOT6/6L in anti-CNOT3 immunoprecipitates from Cnot7/8-dKO MEFs 
expressing CNOT7-WT or CNOT7-CN was comparable to that from control MEFs, while 
much less CNOT6/6L was detected in Cnot7/8-dKO MEFs and those expressing CNOT7-DN 
(Figure 3.5c, d). These data demonstrate that recruitment of CNOT6/6L to the complex by CN 
mutant is not sufficient to rescue the phenotype in Cnot7/8-dKO MEFs suggesting that the 
catalytic activity of DEDD family proteins (CNOT7/8) in the CCR4-NOT complex is essential 
for cell viability.  
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Figure 3.5 CNOT7 catalytic activity is sufficient to maintain MEF viability 
(a) Morphology of Cnot7-KO/Cnot8-flox MEFs infected with the indicated (retro + adeno) 
viruses. (b) Cell death was assessed as in Figure 3.1d (n=3). (c) Lysates were prepared from 
Cnot7-KO/Cnot8-flox MEFs infected with the indicated viruses and subjected to 
immunoprecipitation with anti-CNOT3 antibody. CNOT3 is shown in red to indicate a 
precipitated molecule. Lysates and IP were analyzed by immunoblot. WT: CNOT7 wild-type, 
CN: CNOT7 lacking catalytic activity, DN: CNOT7 dominant negative mutant which lacks 
catalytic activity and an ability to bind to CNOT6/6L. (d) Quantification of the immunoblot 
data in Figure 3.5c. Relative band intensities normalized to those of IP or lysates in control 
MEFs are shown (n=3). Data are presented as mean ± S.E.M. *P<0.05, **P<0.01, ***P< 0.001. 
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3.3.4 Poly(A) tail length of bulk RNAs is elongated in Cnot1-KO and Cnot7/8-dKO 
MEFs 
I next compared deadenylase activity in Cnot1-KO, Cnot7/8-dKO, and Cnot6/6l-dKO MEFs 
with their respective controls, and then examined poly(A) tail lengths of bulk RNAs. In Cnot1-
KO and Cnot7/8-dKO MEFs, the population of mRNAs with poly(A) tail lengths longer than 
50 nt increased, while the population of mRNAs with poly(A) tail lengths shorter than 40 nt 
decreased (Figure 3.6a, b). On the other hand, the distribution of poly(A) tail lengths was 
similar in control and Cnot6/6l-dKO MEFs (Figure 3.6c). I observed a slight increase in the 
population of mRNAs with poly(A) tail lengths of 50 to 100 nt, which is reminiscent of what 
occurs in poly(A)-binding protein (PABP)-mediated prevention of deadenylation, though the 
effect was smaller than in human cancer cell lines (30). These data suggest that deadenylase 
activity is largely impaired in Cnot1-KO and Cnot7/8-dKO, but not in Cnot6/6l-dKO MEFs. 
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Figure 3.6 (previous page) RNAs in Cnot1-KO and Cnot7/8-dKO MEFs have longer 
poly(A) tails compared to those in Cnot6/6l-dKO MEFs 
(a-c) Poly(A) tail lengths of bulk RNA in Cnot1-KO (a), Cnot7/8-dKO (b) and Cnot6/6l-dKO 
MEFs (c) (n=2 for each genotype). Cnot1-flox MEFs infected with mock retrovirus, Cnot7+/+; 
Cnot8-flox MEFs infected with mock retrovirus, and WT MEFs were used as controls, 
respectively. Densitograms of poly(A) tail lengths are shown below each image. The mean of 
two independent experiments was used. This experiment was done by Dr. Akiko Yanagiya. 
3.3.5 Upregulation and stabilization of mRNAs in Cnot1-KO and Cnot7/8-dKO MEFs 
compared to Cnot6/6l-dKO MEFs 
To examine the effects of impaired deadenylation on global gene expression, I performed total 
RNA-seq analysis on Cnot1-KO, Cnot7/8-dKO, Cnot6/6l-dKO MEFs and their respective 
controls. I found that 8257, 1344, and 710 mRNAs were upregulated more than 2-fold in 
Cnot1-KO, Cnot7/8-dKO, and Cnot6/6l-dKO MEFs, respectively, compared with controls 
(Figure 3.7a). The number of upregulated mRNAs in Cnot7/8-dKO MEFs was much smaller 
than that in Cnot1-KO MEFs (Figure 3.3a). In addition, only a few mRNAs decreased in Cnot1-
KO MEFs, whereas 662 mRNAs decreased in Cnot7/8-dKO MEFs when compared with their 
respective controls (Figure 3.7a). Similar results were observed in MCF7 (Aslam et al., 2009). 
These data suggest that CNOT7/8 have deadenylation-independent, CNOT1-independent roles. 
The difference in gene expression between control and Cnot6/6l-dKO MEFs was less 
prominent (Figure 3.7a).  
I next assessed stability of mRNAs based on calculation of mRNA half-lives following 
Act. D chase. The number of stabilized mRNAs was much greater than that of destabilized 
mRNAs in both Cnot1-KO and Cnot7/8-dKO MEFs (Figure 3.7b). While around 2000 mRNAs 
were stabilized in Cnot6/6l-dKO MEFs, a similar number of mRNAs was destabilized (Figure 
3.7b). More than 70% of upregulated mRNAs in Cnot7/8-dKO or Cnot6/6l-dKO MEFs 
overlapped with those in Cnot1-KO MEFs (Figure 3.7c). Similar results were observed in 
stabilized mRNAs (Figure 3.7d). In contrast, less than 50% of upregulated or stabilized 
mRNAs in Cnot6/6l-dKO were observed in Cnot7/8-dKO MEFs (Figure 3.7c, d). These data, 
together with MEF viability data, suggest that the upregulated and stabilized mRNAs common 
to both Cnot1-KO and Cnot7/8-dKO, but not Cnot6/6l-dKO MEFs, are relevant to death of 
MEFs. Gene ontology (GO) analysis indicated that stabilized mRNAs overlapping between 
Cnot1-KO and Cnot7/8-dKO, but not Cnot6/6l-dKO MEFs showed significant enrichment for 
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molecules pertaining to “response to DNA damage stimulus” and “DNA damage repair” 
(Figure 3.7e).  
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Figure 3.7 Gene expression and mRNA stability differ among Cnot1-KO, Cnot7/8-dKO 
and Cnot6/6l-dKO MEFs 
RNA-seq analysis of Cnot1-KO, Cnot7/8-dKO and Cnot6/6l-dKO MEFs compared to controls: 
Cnot1-flox MEFs infected with mock retrovirus, Cnot7+/+; Cnot8-flox MEFs infected with 
mock retrovirus and WT MEFs, respectively (n=2). (a, b) Scatter plots comparing gene 
expression values (a) or mRNA half-lives (b). mRNAs showing expression (a) or half-lives 
(b) that differed more than 2-fold are displayed in black. All values represent means of two 
independent experiments. (c, d) Venn diagrams showing overlap of upregulated (c) or 
stabilized genes (d) (more than 2-fold) in Cnot1-KO, Cnot7/8-dKO and Cnot6/6l-dKO MEFs 
compared to controls. (e) GO analysis of mRNAs stabilized in Cnot1-KO and Cnot7/8-dKO 
but not Cnot6/6l-dKO (upper), or Cnot1-KO and Cnot6/6l-dKO but not Cnot7/8-dKO MEFs 
(lower). Bar charts of the GO terms (Biological Process) ranked by FDR (< 0.05) are shown. 
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Finally, I validated the results of RNA-seq by performing qPCR analysis. I first 
examined levels of Foxo3 and Txnip mRNAs, which are stabilized in both Cnot1-KO and 
Cnot7/8-dKO, but not Cnot6/6l-dKO MEFs in our RNA-seq results (Figure 3.7b). Foxo3 and 
Txnip mRNAs were significantly upregulated in Cnot1-KO and Cnot7/8-dKO MEFs, but not 
in Cnot6/6l-dKO MEFs, compared to controls (Figure 3.8a). I next assessed their stability using 
total RNAs from Act. D-treated cells. Consistent with the results of RNA-seq, both Foxo3 and 
Txnip mRNAs had significantly elongated half-lives in Cnot1-KO and Cnot7/8-dKO MEFs, 
compared to controls (Figure 3.8b). Elongation of their half-lives was less obvious in Cnot6/6l-
dKO MEFs (Figure 3.8b).  
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Figure 3.8 Foxo3 and Txnip mRNAs are upregulated and stabilized in Cnot1-KO and 
Cnot7/8-dKO MEFs 
(a) qPCR analysis of the indicated mRNAs in Cnot1-KO, Cnot7/8-dKO and Cnot6/6l-dKO 
MEFs together with their controls, as in Figure 3.7. Relative mRNA levels were determined by 
qPCR and normalized to the Gapdh mRNA level (n=3). (b) Decay curves of mRNAs. Total 
RNAs were prepared from the indicated MEFs treated with Act. D (0, 4 or 8h). Relative mRNA 
levels were determined as in (a). mRNA levels without Act. D treatment (0h) were set to 100% 
(n=3). Data are presented as mean ± S.E.M. *P<0.05, **P<0.01, ***P<0.001. 
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3.4 Discussion 
Suppression of the CCR4-NOT complex causes severe defects in cytoplasmic deadenylation 
and subsequent degradation of mRNA (Bartlam and Yamamoto, 2010; Collart and Panasenko, 
2012; Tucker et al., 2001). Although many studies have addressed its function in various 
organisms, it was not clear whether its different catalytic subunits serve distinct biological 
functions. In this study, I showed that CNOT7/8, but not CNOT6/6L, are essential for viability 
in MEFs. It is important to emphasize that I evaluated the roles of the CCR4-NOT complex in 
normal cells, by using primary fibroblasts with a less likelihood of mutation, in contrast to 
cancer cell lines. The latter usually contain genetic mutations that promote tumorigenesis, with 
the consequence that malignant cells are governed by different molecular mechanisms and 
signaling pathways than normal cells. 
The decreased viability of Cnot7/8-dKO MEFs was concomitant with a lack of all the 
catalytic subunits in the CCR4-NOT complex (Figure 3.2 and 3.3a). Reintroduction of CNOT7-
WT in Cnot7/8-dKO MEFs recovered cell viability; however, expression of CNOT7-CN and 
CNOT-DN mutants did not (Figure 3.5). This suggests that CNOT7 catalytic activity is critical 
in maintenance of viability because the existence of CNOT6/6L in the complex with the 
introduction of CNOT7-CN mutant didn’t recover MEF viability. Thus, a complex composed 
of CNOT6/6L, catalytically inactive CNOT7, CNOT1 and other subunits fails to function as 
an intact deadenylation complex for maintenance of cell viability.  
Gene expression profiling using RNA-seq revealed a larger contribution of CNOT7/8 
than CNOT6/6L in regulation of global gene expression in MEFs. Similar results have been 
observed in human cell lines, trypanosomes and Drosophila (Schwede et al., 2008; Temme et 
al., 2004). Remarkably, the catalytic effect of CNOT7/8 was more prominent than that of 
CNOT6/6L, as is evident from the results of bulk poly(A) tail analysis, which are clearly 
reflected in mRNA expression (Mittal et al., 2011; Temme et al., 2004) and this study. Absence 
of all known catalytic subunits may partly explain the greater differences in gene expression 
and mRNA stability observed in Cnot7/8-dKO MEFs compared to Cnot6/6l-dKO MEFs, as in 
cell viability. Although CNOT6/6L are not anymore part of the CCR4-NOT complex in 
Cnot7/8-dKO MEFs, genes affected by Cnot6/6l-dKO were not mostly contained within the 
set of mRNAs affected by Cnot7/8-dKO. A similar observation was reported in a previous 
study (Mittal et al., 2011). It is possible that CNOT6/6L deadenylate distinct set of genes apart 
from its association with CNOT7/8 in the CCR4-NOT complex. Interestingly, purified 
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CNOT7/8 and CNOT6/6L exhibit deadenylase activity in vitro (Horiuchi et al., 2009; Raisch 
et al., 2019; Wang et al., 2010). It would be intriguing to examine whether there are complex-
independent CNOT7/8 and CNOT6/6L functions in vivo.  
While target mRNAs and biological processes vary by species (human or mouse) or 
cellular status (transformed or non-transformed), there seems to be a common mechanism by 
which CNOT7/8 and CNOT6/6L regulate distinct groups of mRNAs and biological processes. 
In MCF7, CNOT7/8 are required for cell proliferation, whereas CNOT6/6L are required for 
cell viability (Mittal et al., 2011). Furthermore, upon CNOT7/8 suppression, upregulated or 
stabilized mRNAs showed limited overlap with those upregulated or stabilized by CNOT6/6L 
suppression. A recently proposed model of deadenylation considers the critical involvement of 
PABP on mRNAs, suggesting distinct roles of CNOT7/8 and CNOT6/6L. Specifically, 
CNOT7/8 deadenylate PABP-free poly(A) tails until they encounter PABP, and then 
CNOT6/6L take over, removing PABP and subsequently deadenylating mRNAs (Webster et 
al., 2018; Yi et al., 2018). Importantly, different cell types and cells under different conditions 
vary in their PABP local availability (Yi et al., 2018). This may partly explain the context-
dependent deadenylation activity of CNOT7/8 and CNOT6/6L. In S. cerevisiae, mRNAs have 
higher Pab1 (PABP in yeast) occupancy and consequently, Ccr4, rather than Caf1, contributes 
significantly to deadenylation (Webster et al., 2018). Similarly, mRNAs are saturated with 
PABP in HeLa cells and are deadenylated mainly by CNOT6/6L (Yi et al., 2018). 
Posttranscriptional regulators as miRNA could affect PABP availability. Active translation 
state is relevant to the abundance of PABP on mRNA. Binding of PABP to mRNA is important 
for translation initiation and elongation, because the translation initiation factor complex and 
PABP interact on mRNAs to form closed-loop messenger ribonucleoprotein complexes (Wells 
et al., 1998). On the other hand, miRNA-mediated translational repression causes dissociation 
of PABP from mRNA, leading to mRNA degradation (Zekri et al., 2013). It is possible that 
CNOT6/6L or CNOT7/8 preferentially target mRNAs which are translationally active 
(abundant PABP) or silent (less PABP), respectively, resulting in different biological roles. 
Global analysis of translation status using ribosome profiling should be useful to determine 
whether CNOT6/6L and CNOT7/8 activities are dependent on the mRNA translation status. 
Several lines of evidence show that in addition to its function as a deadenylase, the 
CCR4-NOT complex has nuclear roles in transcription and mRNA export (Collart, 2016). In 
S. cerevisiae, the CCR4-NOT complex interacts with TATA binding protein (TBP) and TBP-
associated factor (TAF) to suppress transcription initiation (Badarinarayana et al., 2000; Collart 
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and Struhl, 1994). It also stimulates transcription elongation through its association with RNA 
polymerase II complexes (Kruk et al., 2011). Moreover, the CCR4-NOT complex is involved 
in transcriptional regulation in mammals (Cejas et al., 2017; Garapaty et al., 2008; Hu et al., 
2009; Neely et al., 2010; Winkler et al., 2006). In our RNA-seq results, not all upregulated 
mRNAs in Cnot1-KO MEFs corresponded to stabilized mRNAs (Figure 3.7). Our group 
previously observed dysregulation in transcriptional mechanisms upon suppression of CNOT1 
or CNOT3 in adipose tissue and in liver, respectively (Suzuki et al., 2019; Takahashi et al., 
2019). These data suggest that suppression of the CCR4-NOT complex transcriptional and 
other nuclear roles could be responsible for upregulation of a subset of genes. Moreover, down 
regulation of a significant number of genes in Cnot7/8-dKO is possibly due to loss of the 
catalytic activity-independent function of CNOT7/8, which positively affects transcription. 
Indeed, CNOT7/8 play a positive role in regulating transcription mediated by the nuclear 
receptors, ERα and RARβ (Morel et al., 2003; Nakamura et al., 2004; Prevot et al., 2001).  
There was not any obvious abnormalities in mouse embryonic development (Mostafa 
et al, 2020), growth to adulthood, or MEF viability in the absence of CNOT6/6L, suggesting 
that CNOT6/6L do not target mRNAs encoding molecules involved in those processes. It is 
also possible that CNOT7/8-mediated deadenylation is sufficient to regulate those mRNAs. 
Yet, CNOT6/6L-mediated mRNA decay is still central to certain biological events. For 
example, CNOT6/6L are critical to survival of MCF7 (Mittal et al., 2011). In NIH3T3 mouse 
fibroblasts, knockdown of CNOT6L causes a severe reduction in proliferation, concomitant 
with significant stabilization of p27kip1 mRNA (Morita et al., 2007). I found that mRNAs 
encoding molecules involved in cell proliferation were enriched among stabilized mRNAs in 
Cnot6/6l-dKO MEFs. Therefore, CNOT6/6L likely regulate proliferation of fibroblasts without 
affecting viability. Furthermore, Cnot6l-KO mice exhibit resistance to diet-induced obesity, 
enhanced energy expenditure, and improved insulin sensitivity (Morita et al., 2019). 
While both Cnot7-KO and Cnot8-KO MEFs are viable, Cnot7/8-dKO MEFs undergo 
death. This is consistent with functional redundancy of CNOT7 and CNOT8, owing to their 
high amino acid sequence similarity (Aslam et al., 2009). Despite this functional redundancy 
in some contexts, as in MEFs (in this study) and MCF7 cells (Aslam et al., 2009), they play 
distinct roles (Berthet et al., 2004; Koch et al., 2014; Nakamura et al., 2004). Cnot8-KO mice 
die in embryo (Mostafa et al, 2020). A specific developmental role of CNOT8 is also observed 
in zebrafish (Koch et al., 2014). Attenuation of Cnot8 in zebrafish caused upregulation of 
developmental control genes and early lethality (Koch et al., 2014). Reciprocally, Cnot7-KO 
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male mice have defects in spermatogenesis, even in the presence of CNOT8 (Berthet et al., 
2004; Nakamura et al., 2004). Differential expression of CNOT7 and CNOT8 could be relevant 
to their specific roles, as previously reported in mouse neural tissues (Chen et al., 2011a). 
Furthermore, their interaction with different proteins may affect their substrate specificities and 
consequently their biological roles. For instance, SMG5/7 endonucleases, which function in 
nonsense-mediated mRNA decay (NMD), preferentially interact with CNOT8 rather than with 
CNOT7 (Loh et al., 2013). Importantly, NMD is essential for embryonic development and 
viability (Hwang and Maquat, 2011). In such a way, I cannot exclude the possibility that 
CNOT8 functions in zebrafish or mouse embryonic development independently of its catalytic 
activity in the CCR4-NOT complex. Further analyses are necessary to address the molecular 
basis for the distinctive functions of CNOT7 and CNOT8. 
To conclude, the data presented in this chapter suggest that maintenance of cell viability 
is one of the fundamental roles of the CCR4-NOT complex, which is mediated mainly by the 
catalytic activity of the CNOT7/8. Their vital importance in regulating global mRNA 
expression is clearly reflected in global gene expression. On the other hand, CNOT6/6L are 
dispensable in MEF viability. However, relatively few biological processes have been 
examined to date. Mouse strains generated with null or conditional alleles for catalytic subunits 
of the CCR4-NOT complex are valuable tools to analyze functions of each catalytic subunit in 
various tissues and biological contexts. 
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 Conclusion and Future prospects 
In this thesis, I uncovered a novel physiological role of CNOT3 in pancreatic β cells. In line 
with my observation that the CCR4-NOT complex expression is deregulated in islets from 
diabetic mice, suppression of the CCR4-NOT complex activity in β cells by knocking out 
Cnot3 led to glucose intolerance and diabetes. These findings raise the possibility that changes 
in CNOT3 expression may contribute to β cell failure in T2D in humans. Thus, it would be 
informative to investigate the expression of CNOT3 in diabetic patients versus healthy donor 
β cells. 
In my model, CNOT3 deletion occurs embryonically at the onset of insulin gene 
expression. Thus, the data I presented here support the role of CNOT3 in the maturation of β 
cells especially the classical markers of β cell maturation such as: MAFA and UCN3 were 
suppressed in Cnot3βKO islets. These data may contribute to the development of diabetes 
therapy through enabling the understanding of the molecular mechanisms that are critical for β 
cell maturation. Achieving β cell maturation presents a major challenge in the generation of 
functional β cells in vitro from embryonic stem cells (D'Amour et al., 2006) or replication from 
existing β cells (Russ et al., 2008) and this can only be tackled with a clear understanding of 
the complex genetic programs that produce and maintain functional β cells. It is currently 
tempting to check if CNOT3 expression varies between different developmental stages: 
progenitor cells, fetal, immature and mature β cells. Studying the effects of knocking out 
CNOT3 at each of these stages would determine whether CNOT3 plays a role in differentiation 
and progression from one stage to another. Moreover, in this study I focused on elucidating the 
role of CNOT3 in β cells only. It will be interesting to investigate its role in other islet cells. 
A detailed molecular mechanism of CNOT3 role in pancreatic β cell function is yet to 
be investigated. Future efforts could shed novel light on RBPs that mediate the interaction of 
CNOT3 with its target genes in β cells. Other mechanisms of CNOT3 function rather than 
mRNA decay are still possible. Global elongation of bulk poly(A) tails in Cnot3βKO islets 
motivated me to find out mRNA targets that CNOT3 is involved in their decay. I suggested 
that CNOT3 is involved in mRNA decay of Aldob and Slc5a10 that are known to be 
upregulated in T2D islets and cause β cell dysfunction (Haythorne et al., 2019). Additionally, 
I suggested the involvement of CNOT3 in the regulation of β cell disallowed genes through 
direct and indirect mechanisms. β cell disallowed genes are presently attractive to study as little 
is known about their functions and the mechanisms involved in their suppression. They hold a 
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good promise as targets for treatment of diabetes because their de-repression contributes to 
T2D.  
A secondary goal of my thesis was to compare the effect of the deletion of the 
deadenylase subunits on CCR4-NOT complex structure and function in MEFs. I concluded 
that either Ccr4-type or Caf1-type deadenylase can have the main deadenylase activity 
depending on the context. The specific KO MEFs I generated in this study form important set 
of tools that will be highly useful to untangle paralog-specific molecular functions of CNOT7 
and/or CNOT8 and CNOT6 and/or CNOT6L. 
Finally, the work in this thesis complements functional studies of the CCR4-NOT 
complex in mammals. Particularly studies investigating its physiological roles, contribution to 
development and pathological implications. Obviously, loss of subunits of the CCR4-NOT 
complex results in serious abnormalities in embryonic development and tissue function, 
suggesting that it is worth to continue studying the biological activities of this complex. This 
may pave the way for eventual development of therapeutics.
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Table 3:  Primers used for genotyping 
Gene Primers 
Cnot3-conditional  
N3 FW CCAGTCTATCTGATGTGGAATTCCTCCATG 
N3 RV AGGCTGGCAGCTCCTGGAAAGGCTAAGAGG 
Cre  
Cre FW TCGATGCAACGAGTGATGAG 
Cre RV TTCGGCTATACGTAACAGGG 
Il-2 (internal control for 
Cre) 
 
Il-2 FW CTAGGCCACAGAATTGAAAGATCT 
Il-2 RV GTAGGTGGAAATTCTAGCATCATCC 
mTmG  
mTmG FW CTCTGCTGCCTCCTGGCTTCT 
mTmG RV CGAGGCGGATCACAAGCAATA 
mTmG Mut RV TCAATGGGCGGGGGTCGTT 
Cnot8-conditional  
N8C FW GACCCTCTCCTACAGACACACATGCCACC 
N8C RV GCAAACAGTGGTGCTCAGCAACCCATGAGC 
Cnot7-null  
N7 FW 
CCAGCCCAGTTTTATAATTCACATTCATGATATTGG
TG 
N7 RV CATCTCTTCATCCAGGTTACAAGCC 
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LacZ2 TGCGCAACTGTTGGGAAGGGCGATC 
Cnot6-null  
N6 FW GTGTGGTCCTTGTTCCATCAGCTCTAAGACATG 
N6 RV CTGGGATTGCATTCACCGTGCATGTTAGGCAG 
N6 flox arm RV GCTAGTTCTTTACAGTCTAGATAGATGGCTCAG 
Cnot6l-null  
N6L WT FW AATGATCCTTTTCCCCCCACAGACTAATAG 
N6L WT RV TATTTTAAAAGATCTAAAAAGAAGTGCCTC 
N6L KO RV TTTCTGCATCCCGGGGATCTGATATCATCG 
Table 4: Primary antibodies used for immunoblot analysis 
Antibody dilution Manufacturer (Cat#) 
CNOT1 1:1000 Proteintech (14276-1-AP) 
CNOT2 1:1000 Proteintech (34214) 
CNOT3 1:1000 Bio Matrix Research Incorporation 
CNOT6 
1:1000 In-house (generated as previously 
described in (Tanaka et al., 2002)) 
CNOT6L 
1:1000 Produced in collaboration with Bio 
Matrix Research Incorporation 
CNOT7 1:1000 Abnova (H00029883-M01) 
CNOT8 1:1000 Produced in collaboration with Bio 
Matrix Research Incorporation 
CNOT9 1:1000 Proteintech (22503-1-AP) 
CNOT10 1:1000 Bethyl Laboratories (A304-899A) 
GAPDH 1:2000 Cell Signaling (2118L) 
α-tubulin 1:1000 Sigma (T9026) 
ALDH1A3 1:1000 Novus biologicals (NBP2-15339) 
MCT1 1:30 Novus biologicals (NBP1-59656) 
LDHA 1:30 Cell Signaling (2012) 
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ALDOB 1:1000 Proteintech (18065-1-1AP) 
Roquin 1:1000 Bethyl Laboratories (A300-514A) 
HuR 1:1000 Cell Signaling (12582) 
Table 5: Secondary antibodies used for immunoblot analysis 
Antibody dilution Manufacturer (Cat#) 
Anti-Rabbit HRP 1:3000 GE healthcare (NA934V) 
Anti- mouse HRP 1:3000 GE healthcare (NA931V) 
Anti-mouse HRP (light 
chain specific) 
1:6000 Jackson immunoresearch laboratories 
(115-035-174) 
Table 6: Primary antibodies used for immunofluorescence analysis 
Antibody dilution Manufacturer (Cat#) 
CNOT3 1:100 Bio Matrix Research Incorporation 
EGFP 1:100 Clontech (632569) 
Insulin No dilution Agilent (IR00261) 
GLUC 1:500 Phoenix pharmaceuticals (H-028-05) 
SST 1:100 Sigma-Aldrich (SAB4502861) 
PPT 
3µg/ml (no 
antigen retrieval) 
Sigma-Aldrich (SAB2500747) 
SYP 1:500 Abcam (ab32127) 
MAFA 1:500 Bethyl Laboratories (IHC-00352) 
GLUT2 5µg/ml Abcam (ab54460) 
Table 7: Secondary antibodies used for immunofluorescence analysis 
Antibody dilution Manufacturer 
Goat-anti-mouse-Alexa-488 1:500 Thermofisher (A-21424) 
Goat-anti-rabbit-Alexa-488 1:500 Thermofisher (A-11008) 
Goat- anti-guinea pig-647 1:500 Thermofisher (A-21450) 
Goat-anti-rabbit-Alexa-555 1:500 Thermofisher (A-21429) 
Donkey-anti-goat-568 1:500 Thermofisher (A-11057) 
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Table 8:  Primers used for qPCR reactions 
Gene Forward (5’-3’) Reverse (5’-3’) 
Ins1 
GAAGTGGAGGACCCACAAGT
G 
CTGAAGGTCCCCGGGGCT 
Ins2 
ATGGCCCTGTGGATGCGCTT 
CTAGTTGCAGTAGTTCTCCAGCTG
G 
Ngn3 GTCGGGAGAACTAGGATGGC AGTCACCCACTTCTGCTTCG 
Aldh1a3 GGGCCTCAGATCGACCAAAA CTAGCTTGGCCCCTTCCTTC 
Myt1 TATGCTTGCCCCAAAGATTC GGCTTTGTGCTGAGGTTCTC 
Dcx GCTGACTCAGGTAACGACCA ACAGGTCTACCTTGTGCTTCC 
Nes CCCTTAGTCTGGAAGTGGCT CTTCAGCTTGGGGTCAGGAAAG 
Tnfrsf11
b GTTTCCCGAGGACCACAAT CCATTCAATGATGTCCAGGAG 
Mafa CAAGGAGGAGGTCATCCGAC TCTCCAGAATGTGCCGCTG 
Nkx2.2  
CGCTACAAGATGAAACGTGC
C 
 CACCTTGCGGACACTATGGG 
Nkx6.1 GAGAGTCAGGTCAAGGTCTG
GT 
TCCGAGTCCTGCTTCTTCTTG 
NeuroD1 TCCCTACTCCTACCAGTCCC CTGGTGCAGTCAGTTAGGGG 
Pdx1 CAGTGGGCAGGAGGTGCTTA GGGCCGGGAGATGTATTTGTT 
Slc2a2 ATTACCGACAGCCCATCCTC AGCACAGAGACAGCCGTGAA 
Pcx GGGCGGAGCTAACATCTACC TATACTCCAGACGCCGGACA 
Gck CTGTTAGCAGGATGGCAGCTT TTTCCTGGAGAGATGCTGTGG 
Cpe GGTACTGCTCACGAATACAGT
TCC 
CTGCTCAGGTAATTGAAGTCTTGC 
Pcsk1 GACCTGCACAATGACTGCAC GGTCCAGACAACCAGATGCT 
Pcsk2 GTTTTTGCGTCTGCCGAGAG CAAAGGGGAGCTTTCGGACT 
Abcc8 TCAACTTGTCTGGTGGTCAGC GAGCTGAGAAAGGGTCATCCA 
Ucn3 GCTGTGCCCCTCGACCT TGGGCATCAGCATCGCT 
Slc30a8 
CAGAGAACTTCGACAGAAGC
C CTTGCTTGCTCGACCTGTT 
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Cacna1c ATGAAAACACGAGGATGTAC
GTT ACTGACGGTAGAGATGGTTGC 
Cacna1d GAAGCTGCTTGACCAAGTTGT AACTTCCCCACGGTTACCTC 
Cacnb2 GCAGGAGAGCCAGATGGA TCCTGGCTCCTTTTCCATAG 
Slc16a1 GCTTGGTGACCATTGTGGAAT CCCAGTACGTGTATTTGTAGTCTC
CAT 
Ldha ATGAAGGACTTGGCGGATGA ATCTCGCCCTTGAGTTTGTCTT 
Hk1 GTGGACGGGACGCTCTAC TTCACTGTTTGGTGCATGATT 
Hk2 GCCTCGGTTTCTCTATTTGGC ATACTGGTCAACCTTCTGCACT 
Rest GCGCACAGTTCAGAGGAGT CATGTTGGCACTGTTGTTGA 
Pdgfra 
GCGAGTTTAATGTTTATGCCT
TG GGCACAGGTCACCACGAT 
Aldob AGAAGGACAGCCAGGGAAAT GTTCAGAGAGGCCATCAAGC 
Slc5a10 ACCTACACTGTGTGTCCCT  CGGCCACATTCAAGGCAAAAT  
Wnt5b AGCACCGTGGACAACACAT AAGGCAGTCTCTCGGCTACC 
Cat TGCCCCCAACTATTACCCCA TCCGCACCTGAGTGACATTG  
Abtb2 CGCTGAGCACGGTTACCT CAGCTTCCAGGGAACACC 
Fgf1 TTATACGGCTCGCAGACACC TCTGGCCATAGTGAGTCCGA 
Yap1 
AAATGCTCCAAAATGTCAGG
A CATTCGGAGTCCCTCCATC 
Igfbp4 AAGATCGTGGGGACACCTC GTGGGTACGGCTCTGTGAG 
Acot7 AGGTGCCTCCCATTGTGTAT TTCTGGGCTTCATAGCGTTT 
Cxcl12 CCCTGCCGGTTCTTCGA CAGCCGTGCAACAATCTGAA 
Foxo3 GCTAAGCAGGCCTCATCTCA TTCCGTCAGTTTGAGGGTCT 
Txnip1 ATCCCAGATACCCCAGAAGC TGAGAGTCGTCCACATCGTC 
Gapdh CTGCACCACCAACTGCTTAG GTCTTCTGGGTGGCAGTGAT 
Table 9: Primers used for 3'UTR cloning 
mRNA Forward (5’-3’) Reverse (5’-3’) 
Slc16a1 cloned as 
two fragments 
  
Slc16a1-A AATCTAGACCTGTGAAGCC
TGGAGAGAG  
AATCTAGACACCCTGTCAAT
TACAATGG 
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Slc16a1-B AATCTAGAGGGTGAATATA
GATTTAAAACC 
AATCTAGAGGACCAAGAAG
ATTGTTTTTTA 
Ldha AATCTAGAAGTCTTCCCCG
TGTCCTAGC 
 
AATCTAGACACTGTTCAAGG
TTTTATTTGG 
 
Wnt5b AATCTAGACTGCACCACAC
GGGCCTTCAGG 
AATCTAGACCTCAGTAAAAA
GATATTTAATGTCAAAGGGA
CGCTGTACATGTGG 
 
Abtb2 AATCTAGAGGCAGGATGGA
GGGGGACTGTTATC 
 
AATCTAGACAATGTTAATGA
GTGTTTATTGTTGATAAAAC
CATAGC 
 
Solutions and buffers used for SDS-PAGE: 
For poly-acrylamide gel preparation: 
30% Acrylamide stock 
146 g Acrylamide 
 4 g Bis-acrylamide 
Dissolved and brought to 500 mL with ddH2O then filtered 
Lower gel buffer 
90.85 g Tris 
2 g SDS 
Dissolved in 400 mL in ddH2O and adjusted to pH 8.8 with HCl then brought to 500 mL with 
ddH2O and filtered 
Upper gel buffer 
30.3 g Tris 
2 g SDS 
Appendix 109 
 
 
Dissolved in 400 mL in ddH2O and adjusted to pH 6.8 with HCl then brought to 500 mL with 
ddH2O and filtered 
For running electrophoresis: 
10x SDS running buffer 
30.0 g Tris 
144.1 g Glycine  
10 g SDS 
Dissolved in ddH2O and adjusted to the volume 1000 mL. 
For immunoblotting: 
10x Transfer buffer 
30.3 g Tris 
144.1 g Glycine 
Dissolved in ddH2O and adjusted to the volume 1000 mL. 
10x TBS 
1M (2M) Tris-HCl (pH 7.5) 200 mL (100 mL) 
87.66 g NaCl 
Dissolved in ddH2O and adjusted to the volume 1000 mL. 
1M Tris-HCL (pH 7.5, 8)  
Dissolved 121.14 g of Tris in ~ 850 mL ddH2O  
Adjusted to pH (7.5 or 8) with HCl then brought to the volume 1000 mL 
TBST 
100 mL 10x TBS  
0.5 mL Tween 20 
Dissolved in ddH2O and brought to the volume 1000 mL 
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3x Sample buffer 
15.6 mL Upper gel buffer 
3.6 g SDS 
12 mL Glycerol 
6 mL 2-mercaptoethanol 
Dissolve with ddH2O and adjust to volume to 40 mL 
 
 
